| scientific journal | Q5633421 |
| P6981 | ACNP journal ID | 19548 |
| P8375 | Crossref journal ID | 376595 |
| P236 | ISSN | 0889-7190 |
| 2375-0952 | ||
| P7363 | ISSN-L | 0889-7190 |
| P4730 | Mir@bel journal ID | 20978 |
| P1055 | NLM Unique ID | 8611947 |
| P856 | official website | http://cufts2.lib.sfu.ca/CJDB/BVAS/journal/316269 |
| http://gateway.ovid.com/ovidweb.cgi?T=JS&MODE=ovid&NEWS=n&PAGE=toc&D=ovft&AN=00002216-000000000-00000 | ||
| http://gateway.ovid.com/ovidweb.cgi?T=JS&MODE=ovid&PAGE=toc&D=ovft&AN=00002216-000000000-00000 | ||
| http://journals.lww.com/asaiojournal/pages/default.aspx | ||
| P10283 | OpenAlex ID | S4210187010 |
| P1156 | Scopus source ID | 32183 |
| P495 | country of origin | United States of America | Q30 |
| P8875 | indexed in bibliographic review | Scopus | Q371467 |
| P407 | language of work or name | English | Q1860 |
| P1476 | title | ASAIO transactions |
| Q42077586 | "Machineless" nutritional hemodialysis |
| Q68622673 | (A)typical symptoms during single needle dialysis |
| Q68368164 | A VAD and novel high performance compact oxygenator for long-term ECMO with local anticoagulation |
| Q69559491 | A bacterial biofilm in a hemodialysis system. Assessment of disinfection and crossing of endotoxin |
| Q69658287 | A bag-filter model of a new prêt à porter artificial kidney |
| Q70153167 | A bioartificial pancreas prevents chronic complications of diabetes in rats |
| Q69658294 | A bioartificial parathyroid |
| Q38595425 | A biodegradable antiadhesion collagen membrane with slow release heparin. |
| Q46190097 | A biolized implantable ventricular assist device compatible with IABP console |
| Q63983774 | A biolized, compact, low noise, high performance implantable electromechanical ventricular assist system |
| Q68622835 | A blood-liquid interface for prolonged extracorporeal oxygenation with excellent antithrombogenicity |
| Q70365691 | A bridge to heart and lung transplantation. PA to LA shunting with an interposed recirculation circuit for oxygenation |
| Q41229608 | A canine model for global control of the reimplanted larynx. A potential avenue for human laryngeal transplantation |
| Q34187220 | A clinical estimation model for noninvasive determination of atrial pressure in total artificial heart patients. |
| Q69440432 | A compact neonatal extracorporeal oxygenator (ECMO) system using a single lumen catheter |
| Q52453174 | A comparative analysis of mass transport models in peritoneal dialysis |
| Q69403631 | A comparison of the antiplatelet effect of aspirin on human and bovine platelets |
| Q67780324 | A completely implantable total artificial heart system |
| Q69440359 | A completely new poly(ether-urethane) graft ideal for hemodialysis blood access |
| Q54380859 | A compliant small-diameter vascular prosthesis lined with functional venous endothelial cells. |
| Q43929990 | A composite driving system for LVAS and IABP: practical and effective driving and weaning |
| Q70391065 | A controlled clinical trial of a new 3-step therapy that includes extracorporeal CO2 removal for ARDS |
| Q69440362 | A femoral vein catheter with immobilized urokinase (UKFC) as an antithrombotic blood access |
| Q44639069 | A heart-lung machine for open-heart operations. How it came about |
| Q68622874 | A high density culture of hepatocytes using a reticulated polyvinyl formol resin |
| Q70228728 | A high efficiency membrane separator for donor plasmapheresis |
| Q67780393 | A hybrid artificial liver system. Function of cultured monolayer pig hepatocytes in plasma from hepatic failure patients |
| Q67977243 | A hybrid artificial vascular graft based upon an organ reconstruction model. Significance and design criteria of an artificial basement membrane |
| Q68020244 | A hybrid bioartificial liver composed of multiplated hepatocyte monolayers |
| Q44456218 | A hydrogel pericardial patch |
| Q46124582 | A mathematical model of continuous arteriovenous hemofiltration predicts performance |
| Q69658506 | A membrane-immobilized monoclonal antibody immunoadsorption system |
| Q52632733 | A model of hemolysis in membrane plasmapheresis. |
| Q67780290 | A model of right ventricular failure after global myocardial ischemia and mechanical left ventricular support |
| Q67780504 | A multicenter study of short hour dialysis using AN69S. Preliminary results |
| Q69658463 | A multicenter trial to evaluate the use of the CAPD "O" set |
| Q41188964 | A muscle powered cardiac assist device for right ventricular support: total assist or partial assist? |
| Q68622725 | A new bioprosthetic cardiac valve with reduced calcification |
| Q69440365 | A new connector system for total artificial hearts. Preliminary results |
| Q69658492 | A new hemostatic material, G.T.XIII |
| Q68202073 | A new hybrid artificial liver using a combination of hepatocytes and biomatrix |
| Q69658491 | A new hydrogel and its medical application |
| Q69403722 | A new implantable burst generator for skeletal muscle powered aortic counterpulsation |
| Q41606545 | A new improved biodegradable tracheal prosthesis using hydroxy apatite and carbon fiber. |
| Q69403758 | A new method of assessing left ventricular function under assisted circulation using a conductance catheter |
| Q35540261 | A new method of determining the solute permeability of hollow-fiber dialysis membranes by means of laser lights traveling along optic fibers |
| Q68202087 | A new percutaneous access device for peritoneal dialysis |
| Q34629560 | A new pulsatile total artificial heart using a single centrifugal pump |
| Q51788025 | A new right ventricular assist device. The extracorporeal pulsatile assist device (EPAD). |
| Q67780387 | A new treatment strategy using both intermittent short dialysis and continuous ambulatory hemofiltration |
| Q69258850 | A new type of low blood flow ECCO2R using a hemodialysis system in apneic states |
| Q41677288 | A newly designed anticancer tumor immunity drug delivery system |
| Q54380856 | A newly designed jellyfish valve for an artificial heart blood pump. |
| Q44947985 | A newly developed drug delivery system using fine particles of activated charcoal for targeting chemotherapy |
| Q69403867 | A novel approach to anticoagulation control |
| Q47589128 | A novel bioreactor based on suspended particles of agarose-immobilized species |
| Q69658305 | A novel elastomeric surgical adhesive: design, properties, and in vivo performances |
| Q44369552 | A novel mechanical cardiac assist device for reversing left ventricular failure |
| Q69258867 | A novel method for long-term respiratory support |
| Q67977175 | A permanent arterial access system |
| Q34629529 | A physical model for the titanium-tissue interface |
| Q68786100 | A piezoelectric driven controlled release micropump for insulin delivery |
| Q69658448 | A portable, pumpless, AV bypass ECCO2R system, with a hollow fiber membrane lung |
| Q69440406 | A potentially implantable thermoelectric sensor for measurement of glucose |
| Q44649849 | A prospective randomized evaluation of chronic peritoneal catheters. Insertion site and intraperitoneal segment. |
| Q67977273 | A protamine filter for extracorporeal blood heparin removal |
| Q50802932 | A protamine-mediated heparin sensing device |
| Q41405487 | A pulmonary mock circulation model for a better understanding of protamine reversal of heparin |
| Q69403699 | A rabbit model for evaluation of an extracorporeal LDL removal system |
| Q69780015 | A rabbit model for implanting continuous drug infusion pumps |
| Q67977141 | A randomized double blind trial of dialysate sodiums of 145 mEq/L, 150 mEq/L, and 155 mEq/L |
| Q38641551 | A rational approach to the therapy of ascites. |
| Q67780283 | A servomatic pneumatic driver system for left ventricular assist devices |
| Q44251449 | A simple and accurate method for prescribing plasma exchange |
| Q69403660 | A simple and compact total artificial heart for temporary use |
| Q67780446 | A simple and practical method for assessing the adequacy of hemodialysis |
| Q69403668 | A simple method for rapid and precise estimation of the protamine dose required for clinical heparin reversal |
| Q67977240 | A simplified approach to monitoring in vivo therapy prescription |
| Q45287363 | A sophisticated electromechanical ventricular simulator for ventricular assist system testing |
| Q70134891 | A standardized system for describing flow/pressure relationships in vascular access devices |
| Q67780350 | A survey of permanent double lumen catheters in hemodialysis patients |
| Q69811190 | A sustained release anticancer device |
| Q67977295 | A synthetic tetrapeptide as a novel platelet-preserving agent during cardiopulmonary bypass |
| Q68622626 | A tether-free, moving actuator total artificial heart |
| Q43465659 | A theoretical study of new types of valve shunts for cerebrospinal fluid |
| Q69403916 | A thin-film glucose electrode system with compensation for drift |
| Q52123067 | A titanium-nickel alloy intravascular endoprosthesis. In vitro studies. |
| Q68622611 | A total artificial heart for neonates allowing bridging to transplantation |
| Q51770381 | A total heart/lung bypass simulator. |
| Q68622639 | A transcutaneous optical information transmission system for implantable motor-driven artificial hearts |
| Q67977304 | A tricuspid polyurethane heart valve as an alternative to mechanical prostheses or bioprostheses |
| Q69403777 | A unique left-right flow imbalance compensation scheme for an implantable total artificial heart |
| Q43822072 | A unique vascular graft concept for coronary and peripheral applications |
| Q63983778 | A unique, efficient, implantable, electromechanical, total artificial heart |
| Q41391548 | AL preincubation inhibits calcification of bioprosthetic heart valve tissue in the rat subdermal model |
| Q68360562 | ASAIO Transactions Initiates Peer Review |
| Q41148905 | ASAIO presidential address |
| Q69403625 | Absence of rejection in cryopreserved saphenous vein allografts for hemodialysis |
| Q38641543 | Absorption of fluid and solutes from the peritoneal cavity. Theoretic and therapeutic implications and applications |
| Q68644872 | Absorption of sulfamethoxazole and albumin from the peritoneal cavity |
| Q64940066 | Accumulation of serum amyloid P and its deposition in the carpal tunnel region of long-term hemodialysis patients. |
| Q68622675 | Acellular matrix allograft small caliber vascular prostheses |
| Q42643420 | Activation of neutrophil oxidative metabolism during cardiopulmonary bypass with membrane oxygenators |
| Q69658318 | Acute fatal hyperaluminemic encephalopathy in undialyzed and recently dialyzed uremic patients |
| Q68142773 | Acute respiratory failure. On how to injure healthy lungs (and prevent sick lungs from recovering) |
| Q68622764 | Additional salutary hemodynamic effects of the combined use of the paraaortic counterpulsation device and intraaortic balloon pump versus a paraaortic counterpulsation device alone |
| Q67706530 | Administration of haptoglobin during cardiopulmonary bypass surgery |
| Q68020215 | Adult ECMO performed with surface-heparinized equipment |
| Q45084329 | Advances and new concepts in the designing of peritoneovenous shunts for the treatment of refractory ascites |
| Q67780499 | Advances in design principle and fluid dynamics of a flexible polymeric heart valve |
| Q68786093 | Al+++ binding studies and metallic cation effects on bioprosthetic heart valve calcification in the rat subdermal model |
| Q44915573 | Altered humoral control of circulating volume during artificial circulation |
| Q68622744 | Altered pattern of calcium kinetics in hemodialysis patients after parathyroidectomy |
| Q69403879 | Aluminum toxicity and albumin |
| Q70412702 | Aminodiphosphonate or AI preincubation inhibits calcification of aortic homografts in the rat subdermal model |
| Q45287997 | Aminoglycoside binding to polyacrylonitrile hemofilter membranes during continuous hemofiltration. |
| Q126561460 | An In Vitro Test Model to Study the Performance and Thrombogenecity of Cardiovascular Devices |
| Q68020241 | An adsorption and filtration technique for temporary hepatic assistance |
| Q69403762 | An ambulatory, intermediate term left ventricular assist device |
| Q44301170 | An analysis of thermal regulation in hemodialysis with one and three compartment models |
| Q68622633 | An artificial heart driven by liquid gas |
| Q69403617 | An autologous connective tissue tube with high healing ability as a small diameter vascular substitute with temporary antithrombogenicity |
| Q69658398 | An automated plasma collector with innovative membrane and cassette-like disposable set |
| Q68622819 | An efficient method for removing bilirubin |
| Q44592971 | An electrohydraulic total artificial heart with a separately placed actuator |
| Q69403753 | An electrohydraulic ventricular assist system with a linear actuator |
| Q67977269 | An electromagnetic pneumatic blood pump driver |
| Q43577244 | An electromagnetically controllable heart valve suitable for chronic implantation |
| Q67918996 | An enhanced outlet port clamp for blind patients on CAPD using the UVXD device |
| Q68622815 | An extracorporeal perfusion system to bridge pediatric liver transplant candidates |
| Q68622869 | An implanted peritoneal oxygen tonometer that can be calibrated in situ |
| Q51629253 | An improved glycerol/insulin formulation for use in implantable pumps. |
| Q70134877 | An in vitro evaluation of an artificial heart |
| Q70388609 | An in vitro model for chemical extraction of carbon dioxide via modified peritoneal dialysis |
| Q67977219 | An in vitro model for human endothelial cell seeding of a small diameter vascular graft |
| Q69403882 | An in vitro test model to study the performance and thrombogenicity of cardiovascular devices |
| Q44672070 | An integrated artificial heart-lung device. |
| Q68510649 | An intraperitoneal insulin regimen for diabetics on continuous cyclic peritoneal dialysis |
| Q54449951 | An intraperitoneal receptacle for macroencapsulated endocrine tissue. |
| Q68622713 | An intrathoracic left ventricular assist system: utilization of results from a development program |
| Q70365712 | An intravenacaval blood gas exchange (IVCBGE) device. A preliminary report |
| Q46269800 | An on-line monitor of dialyzer Na and K flux in hemodialysis. |
| Q69403745 | An original inflow cannula for paracorporeal assist devices |
| Q39608524 | An update on adult extracorporeal membrane oxygenation-extracorporeal CO2 removal |
| Q67977162 | Analysis of solute clearance and flux in pre- and post-dilution hemofiltration |
| Q69403910 | Anatomic considerations for abdominally placed permanent left ventricular assist devices |
| Q63983772 | Anatomic fit study for development of a one piece total artificial heart |
| Q44296945 | Anatomic interaction between the right and left ventricles during univentricular and biventricular circulatory support |
| Q67780296 | Anatomic study for in vivo evaluation of a total artificial heart in calves |
| Q67706527 | Angiopolarity: a new design parameter for cell transplantation devices and its application to degradable systems |
| Q35336094 | Angioscopy in transluminal balloon and laser angioplasty in the management of chronic hemodialysis fistulae |
| Q69658421 | Animal model for ethylene oxide (EtO) associated hypersensitivity reactions |
| Q44967528 | Another way of pumping blood with a rotary but noncentrifugal pump for an artificial heart |
| Q68100293 | Anticoagulant and membrane effects on humoral and cellular changes during plasmapheresis |
| Q67780307 | Antidiuretic hormone regulation in hemodialysis |
| Q67977127 | Antithrombogenicity of ventricular assist devices for postoperative myocardial dysfunction |
| Q69403628 | Aortocoronary bypass grafting with hydrophilic small caliber vascular grafts |
| Q44493916 | Application of a new nuclear scintigraphy camera to evaluate flow and mechanical pumping of artificial hearts |
| Q68915290 | Application of a prostacyclin analogue (PG) and protease inhibitor (FUT) as anticoagulants with an LVAD system |
| Q68915316 | Application of an antithrombogenic Anthron bypass tube to experimental orthotopic liver transplantation. Studies on blood coagulation and fibrinolysis |
| Q52447492 | Application of finite element analysis for assessing biocompatibility of intra-arterial catheters and probes |
| Q68808721 | Application of small-caliber heparinized vascular grafts to aorta-coronary bypass grafting |
| Q69626307 | Application of surfaces with end point attached heparin to extracorporeal circulation with membrane lungs |
| Q69559488 | Are high flux dialysis and erythropoietin treatment in a collision course? |
| Q39644719 | Are there limitations to shortening dialysis treatment? |
| Q68202020 | Arteriovenous shunt flow measurement by ultrasonic duplex system |
| Q68622577 | Artificial heart. Hemorrheology and transient ischemic attacks |
| Q69403866 | Atherosclerosis in uremic mice |
| Q67780329 | Atrial compliance changes in animal total artificial heart recipients |
| Q44671275 | Atrial natriuretic factor production and secretion during clinical total artificial heart-bridge-to-transplantation |
| Q41817746 | Attenuation of pulmonary leukocyte sequestration during extracorporeal circulation by a new c-AMP phosphodiesterase inhibitor |
| Q51788919 | Augmentation of CO2 transfer in membrane lungs by the infusion of a metabolizable organic acid. |
| Q67977225 | Augmented hemoperfusion for hyperbilirubinemia |
| Q69440440 | Autostatic endourethral prosthesis for long-term modeling-replacement of the male urethra |
| Q69440356 | Axillary artery to iliac vein vascular access using an externally supported prosthetic graft. A new procedure for the recalcitrant secondary access patient |
| Q44861446 | Backdiffusion rather than backfiltration enhances endotoxin transport through highly permeable dialysis membranes |
| Q67977231 | Backfiltration: does it occur in membrane plasma separation? |
| Q41728867 | Basic studies on a new material for inducing antitumor immune cells |
| Q52529028 | Bedside formulas for K.t/V. A kinder, gentler approach to urea kinetic modeling. |
| Q67780429 | Behavioral and biochemical indices of compliance in hemodialysis patients |
| Q43559307 | Benefit of bicarbonate dialysis during CAVHD. |
| Q69258831 | Beta 2-microglobulin kinetics in an ovine model |
| Q70242924 | Beta-2 microglobulin serum levels in maintenance dialysis. What does it mean? |
| Q69658499 | Bilirubin removal from a jaundiced premature infant by resin hemoperfusion |
| Q69844093 | Bioartificial pancreas in autoimmune nonobese diabetic mice |
| Q67780490 | Bioartificial thyroid. The in vitro culture of microencapsulated rabbit thyroid tissue |
| Q44575019 | Biocompatibility of dialysis membranes is of no importance for objective or subjective symptoms during or after hemodialysis |
| Q68622658 | Biocompatible coatings with high albumin affinity |
| Q38781253 | Biodegradable polymers for drug delivery to the brain |
| Q68622760 | Bioenergetic recovery processes of injured myocardium |
| Q67819743 | Biofilm formation on peritoneal catheters does not require the presence of infection |
| Q68169160 | Biologic versus bionic heart substitutes. Will xenotransplantation play a role? |
| Q41822108 | Biomaterial associated impairment of local neutrophil function |
| Q68622602 | Biomaterial calcification without direct material-cell interaction |
| Q39760636 | Biomaterial-associated infection, neoplasia, and calcification. Clinicopathologic features and pathophysiologic concepts |
| Q41155782 | Biomaterials science, medical devices, and artificial organs. Synergistic interactions for the 1990s |
| Q67977266 | Biomechanical circulatory assistance. Importance of aerobic capacity of normal and conditioned skeletal muscles |
| Q67977257 | Bioprosthetic valve calcification and pseudoneointimal proliferation in bovine and ovine models |
| Q69714851 | Biosensors |
| Q68531923 | Biosensors in artificial organs |
| Q69440490 | Bisected diastolic driving to control combined clinical use of left ventricular assist device and intraaortic balloon pumping and its effect on renal function |
| Q67780299 | Blood compatibility of the jellyfish valve without anticoagulant |
| Q69658444 | Blood flow and surface-induced thrombosis |
| Q44709523 | Blood purification for postoperative liver failure with special reference to chronic hepatic support for those awaiting liver transplantation |
| Q68531915 | Blood substitutes based on modified hemoglobin and fluorochemicals |
| Q67977196 | Blood-dialysate equilibration during continuous arteriovenous hemodialysis |
| Q67780379 | Bovine pericardial valves. Nine-year clinical experience with the Novacor left ventricular assist system |
| Q50882876 | Brain edema and the blood brain barrier in galactosamine-induced fulminant hepatic failure rats. An animal model for evaluation of liver support systems. |
| Q68915286 | Bridge to cardiac transplantation: successful use of prosthetic biventricular support in a patient awaiting a donor heart |
| Q61662682 | Buffer balance in bicarbonate hemodiafiltration |
| Q44280229 | CO2 removal for ventilatory support: a comparison of dialysis with and without carbonic anhydrase to a hollow fiber lung. |
| Q69119880 | CO2 removal with hemodialysis and control of plasma oncotic pressure |
| Q44060326 | Calcium antagonists improve ultrafiltration in patients on continuous ambulatory peritoneal dialysis (CAPD). |
| Q57227550 | Calcium carbonate as a phosphate binder in hemodialysis patients |
| Q57227380 | Calcium carbonate as a phosphate binder. One year's experience |
| Q57226944 | Calcium carbonate powder as a phosphate binder |
| Q57227552 | Calcium carbonate. A better phosphate binder than aluminum hydroxide |
| Q47572209 | Can our society afford mechanical hearts? |
| Q68915297 | Carbacyclin derivative (CS-570). A new anticoagulant for hemodialysis |
| Q68622608 | Cardiac arrest after hypertonic citrate anticoagulation for chronic hemodialysis |
| Q67977101 | Cardiac disuse atrophy during LVAD pumping |
| Q45172994 | Cardiopulmonary bypass with a surface-heparinized extracorporeal perfusion system |
| Q67780359 | Catheter with an anchoring tip for chronic joint capsule perfusion |
| Q43572091 | Causes of intraaortic balloon leaks |
| Q39661739 | Cell adhesion to biomaterials. The role of several extracellular matrix components in the attachment of non-transformed fibroblasts and parenchymal cells |
| Q42514411 | Cellular control of membrane permeability. Implications for a bioartificial renal tubule |
| Q43500526 | Challenge of phagocyte metabolism by extracorporeal circulation and membrane contact. A biocompatibility test |
| Q68622855 | Change in intracellular calcium ions during shear induced platelet aggregation |
| Q43727613 | Change in sympathetic activity before, during, and after dialysis-induced hypotension. |
| Q52426632 | Changes in blood parameters during hemodialysis as determined by conductivity measurements. |
| Q45050253 | Changes in blood volume during dialysis are dependent upon the rate and amount of ultrafiltrate |
| Q67977236 | Changes in electrical charge of leukocyte surface membranes during hemodialysis. Possible role in transient leukopenia |
| Q67905169 | Changes in endothelial vasoactive substances under recombinant human erythropoietin therapy in hemodialysis patients |
| Q68808724 | Changes in interleukin-1 during membrane plasmapheresis |
| Q69403807 | Characteristic profiles of circulating blood volume during dialysis therapy |
| Q64914356 | Characteristics of blood rheology in patients during Novacor left ventricular assist system support. |
| Q35631895 | Characterization of blood microemboli associated with ex vivo left ventricular assist devices in a bovine model |
| Q69403645 | Characterization of natural and total artificial heart acceleration |
| Q48904169 | Characterizing sleep disorders in chronic hemodialysis patients |
| Q68389034 | Charcoal hemoperfusion. Reminiscences and prejudices |
| Q39677498 | Choice of heart valves |
| Q69658379 | Chromatographic studies of aluminum-desferrioxamine complex in uremic patients |
| Q67977262 | Chronic effect of left ventricular assist pumping on right ventricular function |
| Q43544852 | Chronic evaluation of a compact nonseal magnet pump as a nonpulsatile pump for long-term use |
| Q44767022 | Chronic in vivo evaluation of a portable electrohydraulic ventricular assist system with a linear actuator |
| Q68622805 | Chronic nightly tidal peritoneal dialysis |
| Q69403719 | Chronic ovine evaluation of a totally implantable electrical left ventricular assist system |
| Q68622574 | Circulatory support at the turn of the decade. A clinician's view |
| Q67977200 | Citrate for regional anticoagulation. Effects on blood PO2, ammonia, and aluminum |
| Q68360537 | Clinical Implications of Catheter Variability on Neonatal Continuous Arteriovenous Hemofiltration |
| Q57226565 | Clinical application of low calcium peritoneal dialysate |
| Q68389023 | Clinical aspects of high efficiency hemodialysis |
| Q38017626 | Clinical choices for circulatory assist devices |
| Q68808731 | Clinical consideration of a left ventricular assist system for acute myocardial infarction with cardiogenic shock |
| Q33400887 | Clinical effects of a polyethylene glycol grafted cellulose membrane on thrombogenicity and biocompatibility during hemodialysis |
| Q41814488 | Clinical effects of recombinant human erythropoietin in hemodialysis patients. Results of the "Abruzzo" Multicenter Trial |
| Q69658436 | Clinical evaluation of a multilayered cryofilter for highly selective cryoglobulin removal |
| Q33285090 | Clinical evaluation of the Novacor totally implantable ventricular assist system. Current status |
| Q67977276 | Clinical experience with a new hemodiafiltration (HDF) system |
| Q46467114 | Clinical experience with centrifugal pump ventricular support at UCLA Medical Center. |
| Q68202066 | Clinical experience with textured blood contacting surfaces in ventricular assist devices |
| Q69403854 | Clinical experience with the Hemopump |
| Q68622825 | Clinical experience with the Nimbus pump |
| Q70228717 | Clinical significance of a dialysis membrane that can remove beta 2-microglobulin (beta 2m) |
| Q69403636 | Clinical trial of a self-sealing PTFE-silicone dialysis graft |
| Q36432451 | Clinical trials of the BioLogic-HD. Automated single access, sorbent-based dialysis |
| Q69658428 | Clinical trials with predilution and vacuum suction: enhancing the efficiency of the CAVH treatment |
| Q53033354 | Clinical use of the Berlin Biventricular Assist Device as a bridge to transplantation. |
| Q69440386 | Clinical, morphologic, biochemical, and immunohistochemical aspects of dialysis-associated amyloidosis |
| Q70311566 | Coagulation and fibrinolysis in chronic renal failure. Change in tissue-type plasminogen activator activity |
| Q68927157 | Coagulation problems in artificial organs |
| Q44513501 | Collagen sealed Dacron. Implantation for congenital and acquired cardiac defects |
| Q67780485 | Combined LDL apheresis and hemodialysis in a patient with end-stage renal disease and accelerated coronary atherosclerosis |
| Q42094415 | Combined administration of protease inhibitor and thromboxane A2 synthetase inhibitor for anticoagulation of a left ventricular assist device |
| Q68714596 | Combined registry for the clinical use of mechanical ventricular assist devices. Postcardiotomy cardiogenic shock |
| Q43825813 | Comparative analysis of thrombogenicity and clinical patency between woven and knitted aorto-iliac and aorto-femoral prostheses. |
| Q70228687 | Comparative clinical trial of regional anticoagulation for hemodialysis |
| Q63984942 | Comparative in vitro encrustation studies of biomaterials in human urine |
| Q67977285 | Comparative in vitro evaluations of vascular graft compliance during dynamic loading |
| Q45106909 | Comparative rates of antibiotic action against Staphylococcus epidermidis biofilms |
| Q70365678 | Comparative study of anticoagulation therapy with an LVAD system |
| Q43556723 | Comparison of 50% dextrose water, 25% mannitol, and 23.5% saline for the treatment of hemodialysis-associated muscle cramps |
| Q63984932 | Comparison of Delphin and BioMedicus pumps |
| Q67780399 | Comparison of an extraaortic counterpulsation device versus intraaortic balloon pumping in severe cardiac failure |
| Q69658332 | Comparison of clinical and animal recipients of a pneumatic artificial heart |
| Q43709339 | Comparison of conductivity measured hematocrit to microhematocrit |
| Q44367995 | Comparison of continuous arteriovenous hemofiltration and continuous arteriovenous dialysis in critically ill patients |
| Q69403775 | Comparison of direct mechanical ventricular actuation and cardiopulmonary bypass |
| Q47445121 | Comparison of low molecular weight heparin and standard heparin in hemodialysis |
| Q67780527 | Comparison of microsphere and intraoperative quantitation of bronchial blood flow |
| Q67977168 | Comparison of peritonitis rates using standard spike versus Y sets in CAPD |
| Q69658388 | Comparison of plasmafractionation filters and filtration techniques in the clinical practice of LDL-apheresis |
| Q41811498 | Comparison of pressure-volume-flow relationships in centrifugal and roller pump extracorporeal membrane oxygenation systems for neonates |
| Q45948034 | Comparison of right ventricular and biventricular circulatory support in a porcine model of right heart failure. |
| Q68622599 | Complement activation and use of a cell saver in cardiopulmonary bypass |
| Q68808713 | Complement activation produced by biomaterials |
| Q41283428 | Compliance effect on patency of small diameter vascular grafts |
| Q68622758 | Complications of Tenckhoff catheters post removal |
| Q38641585 | Complications of peritoneovenous shunts |
| Q46604557 | Component selection to optimize blood flow for continuous arteriovenous hemofiltration and dialysis |
| Q41283413 | Computer model of ventricular interaction during left ventricular circulatory support |
| Q68622629 | Computer simulation of the circulatory system during support with a rotary blood pump |
| Q67977306 | Computerized intraoperative calculation of instantaneous prosthetic aortic valve area |
| Q68786107 | Computerized tomography with and without intraperitoneal contrast for determination of intraabdominal fluid distribution and diagnosis of complications in peritoneal dialysis patients |
| Q69403620 | Concentration profiles of 1 and 2.5 microns beads during blood flow. Hematocrit effects |
| Q69440457 | Conductivity measurements for analysis of transcellular fluid shifts during hemodialysis |
| Q69658468 | Continuous arterio-venous hemofiltration in a wearable device to treat end-stage renal disease |
| Q39644729 | Continuous arteriovenous hemofiltration for acute renal failure. |
| Q69658394 | Continuous arteriovenous hemofiltration for the treatment of anasarca and acute renal failure in severely burned patients |
| Q67780316 | Continuous measurement of pressure in internal arteriovenous fistulae and prevention of symptomatic hypotension during hemodialysis |
| Q52422894 | Continuous monitoring of artificial heart pump performance |
| Q67819736 | Continuous pH and HCO3 monitoring during hemodiafiltration without blood sampling |
| Q69658401 | Continuous renal replacement therapy in patients with acute renal dysfunction undergoing intraaortic balloon pump and/or left ventricular device support |
| Q69658308 | Contractile behavior of electrically activated mechanochemical polymer actuators |
| Q69714840 | Control of cardiac replacement |
| Q67780493 | Control of cellular orientation in two-dimensional tissue formation. Surface topologic effect of collagen fibers on endothelialization |
| Q52447484 | Control of pulsatile rotary pumps without pressure sensors |
| Q42495889 | Control of water flux in a bioartificial kidney |
| Q47588052 | Controlled preclotting--a simplified technique proved by time. |
| Q69028799 | Conversion of ammonia or urea into L-leucine, L-valine, and L-isoleucine using artificial cells containing an immobilized multienzyme system and dextran-NAD+. Glucose dehydrogenase for co-factor recycling |
| Q45913763 | Correlates of decade-long technique survival on home hemodialysis. |
| Q39514586 | Correlation of gross and microscopic appearance of skin buttons in total artificial heart animals |
| Q67905168 | Cost and cost effectiveness of the mechanical and pharmacologic bridge to transplantation |
| Q43760904 | Cost and reimbursement rates for investigational circulatory support |
| Q67977152 | Couette membrane filtration with constant shear stress |
| Q47355949 | Cumulative clinical experience with the Symbion J7 TAH. |
| Q68808742 | Cuprophan membrane induces interleukin-1 activity |
| Q69361370 | Current perception threshold. Reproducibility and comparison with nerve conduction in evaluation of carpal tunnel syndrome |
| Q67977098 | Current perception: preferred test for evaluation of peripheral nerve integrity |
| Q38641506 | Current status of pancreas transplantation |
| Q70228697 | Cystatin C: a new marker of biocompatibility or a good marker for the redistribution of LMW proteins during hemodialysis? |
| Q67780444 | Cytokine levels during hemodialysis |
| Q69258790 | Cytokine-induced peritoneal fibrosis in CAPD. Effects of Ca++ and 1,25(OH)2D3 |
| Q69658472 | Daily clearances with continuous ambulatory peritoneal dialysis and nightly peritoneal dialysis |
| Q67780534 | Decreased technique-related morbidity for continuous ambulatory peritoneal dialysis |
| Q69440463 | Degradation by gamma irradiation of regenerated cellulose membranes for clinical dialysis |
| Q68622731 | Delrin as an occluder material |
| Q67977211 | Deposition of blood elements on vacuum-formed ventricles in calves. A gross and electron microscopic study |
| Q69714857 | Design criteria for ferroelectric polymer sensors and their applications to artificial organ technology |
| Q68622614 | Design mediated thrombus reduction in the Utah-100 total artificial heart |
| Q44428574 | Design of a plasma separator using ceramic membranes |
| Q68622728 | Detailed examination of complete bioprosthetic heart valves |
| Q54728063 | Detection of bacteria in dialysate and its antibody in long-term hemodialysis patients. |
| Q70228693 | Detection of electrophoretic heterogeneity of serum beta 2-microglobulin in chronic renal failure |
| Q67780254 | Determinants of dialyzer reuseability |
| Q67780344 | Determinants of measured dialysis venous pressure and its relationship to true intra-access venous pressure |
| Q67977104 | Determinants of survival in patients with ventricular assist devices |
| Q47428367 | Determination of atrial shunt size needed to balance an electrohydraulic total artificial heart |
| Q67780332 | Determination of critical pericardial dimensions in patients with dilated cardiomyopathy |
| Q37923476 | Determining ultrafiltration properties of the peritoneum. |
| Q69403845 | Development and clinical application of a new CAPD connection system--Safedap |
| Q68622809 | Development and evaluation of a wearable blood glucose monitor |
| Q67780488 | Development of a 3-D artificial extracellular matrix. Design concept and artificial vascular media |
| Q67977188 | Development of a completely implantable total artificial heart |
| Q69361377 | Development of a compliant surgical adhesive derived from novel fluorinated hexamethylene diisocyanate |
| Q69658407 | Development of a fine ceramic heart valve for use as a cardiac prosthesis |
| Q67977137 | Development of a growable vascular graft |
| Q69403907 | Development of a new circulatory assist method with the combined effects of intra-aortic balloon pumping and counter pulsation. First report |
| Q68020230 | Development of a new long-term access device for continuous ambulatory peritoneal dialysis |
| Q42468556 | Development of a new scrim cardiac wall substitute |
| Q52107267 | Development of a new transvenous patent ductus arteriosus occlusion technique using a shape memory polymer. |
| Q69403881 | Development of a novel artificial matrix with cell adhesion peptides for cell culture and artificial and hybrid organs |
| Q69361373 | Development of a novel biocompatibility test method based on intracellular calcium ion mobilization |
| Q52592749 | Development of a novel membrane apheresis system for plasma collection at mobile sites. |
| Q68622792 | Development of a novel potent peptidyl platelet preserving agent: molecular design and biologic activity |
| Q68622685 | Development of a polyurethane percutaneous access device for long-term vascular access |
| Q69658502 | Development of a regenerated cellulose non-complement activating membrane for hemodialysis |
| Q43957385 | Development of a small caliber biologic vascular graft: evaluation of its antithrombogenicity and the early healing process |
| Q69658281 | Development of a small caliber vascular graft by a new crosslinking method incorporating slow heparin release collagen and natural tissue compliance |
| Q70412689 | Development of a small-caliber vascular graft with antithrombogenicity induced by extreme hydrophilicity |
| Q68622678 | Development of a soft, pliable, slow heparin release venous graft |
| Q51607778 | Development of a totally implantable total artificial heart controller |
| Q68368175 | Development of alumina ceramic transcutaneous connector to prevent skin exit site infections around CAPD catheters |
| Q41405512 | Development of an anaphylatoxin scavenging device. Principle, surface molecular design, and selective adsorption. |
| Q67977205 | Development of an antithrombogenic cardiac wall substitute which can be reconstructed by infiltration of host cells |
| Q68622649 | Development of an artificial extracellular matrix. Solution castable polymers with cell recognizable peptidyl side chain |
| Q42010587 | Development of an autologous connective tissue tube as a small caliber vascular substitute |
| Q52447450 | Development of an automatic control algorithm for the electrohydraulic total artificial heart without transducers |
| Q68622623 | Development of an efficient electrohydraulic total artificial heart |
| Q70228710 | Development of an epicardial circulatory assist device |
| Q67780361 | Development of an implantable drug delivery catheter |
| Q54545742 | Development of an interleukin-2 slow delivery system. |
| Q69403873 | Development of an intravascular lung assist device |
| Q69403825 | Development of hybrid compliant graft: rapid preparative method for reconstruction of a vascular wall |
| Q68622790 | Development of micropatterning technology for cultured cells |
| Q68622617 | Development of the E4T electrohydraulic total artificial heart |
| Q67780270 | Development of thermosensitive peptidyl cell substrate synthesis and artificial fibrin glue |
| Q69119866 | Development of ultrafine polyester fiber vascular grafts with high endothelialization capability. Angiogenesis by ultrafine polyester fibers |
| Q67780338 | Device related infections in patients supported with mechanical circulatory support devices for greater than 30 days |
| Q68020248 | Diagnosis and surgical treatment of erectile dysfunction |
| Q69403804 | Dialysate contamination and back filtration may limit the use of high-flux dialysis membranes |
| Q68714580 | Dialysis-related amyloidosis during peritoneal dialysis |
| Q68714591 | Dialyzer urea and creatinine clearances are not significantly altered in erythropoietin treated maintenance hemodialysis patients |
| Q68622828 | Difference in beta 2-microglobulin removal between cellulosic and synthetic polymer membrane dialyzers |
| Q52423964 | Differential light scattering cuvettes for the measurement of thromboemboli in high shear blood flow systems. |
| Q52593833 | Diffusive and convective mass transport characteristics in beta 2-microglobulin removal. |
| Q67918997 | Direct measurement of pulmonary and systemic flow during assisted circulation |
| Q69440496 | Direct mechanical ventricular assistance promotes salvage of ischemic myocardium |
| Q69403809 | Disappearance of oxidative damage to red blood cell membranes in uremic patients following renal transplant |
| Q68915320 | Disseminated intravascular coagulation (DIC) during long-term bypass: incidence and clinical relevance |
| Q67780480 | Do humoral factors removed by plasmapheresis suppress the cellular immune system in cryoglobulinemia? |
| Q34190352 | Drive system management of emergency conditions in three permanent total artificial heart patients |
| Q46077803 | Dynamic internal compliance measurements of fresh and fixed artery. |
| Q45042633 | Dynamic internal compliance of a vascular prosthesis |
| Q35631905 | Dynamics of platelet adhesion to artificial materials and cultured endothelial cells under shear flow. |
| Q44533871 | ECMO assisted angioplasty for cardiomyopathy patients with unstable angina |
| Q37188522 | ECMO in premature infants. Review of factors associated with mortality |
| Q68622784 | Early and late tamponade with the Novacor left ventricular assist system |
| Q68169165 | Early days of hemofiltration |
| Q67780354 | Easy access for a left ventricular assist system without thoracotomy |
| Q40785148 | Easy production of sterile, pyrogen-free dialysate |
| Q70311575 | Effect of CAVH membrane types on drug-sieving coefficients and clearances |
| Q53740198 | Effect of a hydrogel with long polyethyleneoxide chains on blood coagulation and fibrinolysis. |
| Q43788000 | Effect of a leukocyte-platelet removal filter on ischemia induced reperfusion injury. |
| Q34242920 | Effect of a pulsing electromagnetic field on metabolically derived osteoporosis in rats: a pilot study |
| Q93529643 | Effect of a total artificial heart on adaptive hormonal responses in humans with end-stage heart failure |
| Q69658321 | Effect of antiplatelet drugs on human endothelial cell growth in tissue culture |
| Q44769846 | Effect of beta cell distribution on the performance of a bioartificial pancreas |
| Q69440400 | Effect of blood and ultrafiltrate flow rates on drug sieving during continuous hemofiltration |
| Q44508157 | Effect of chemical germicides on the integrity of hemodialyzer membranes. |
| Q68622883 | Effect of complement and arachidonic acid pathway inhibition on white blood cell count and deposition on vascular grafts |
| Q67977133 | Effect of desferrioxamine infusion on red blood cell aluminum |
| Q46845873 | Effect of diphosphonate binding to collagen upon inhibition of calcification and promotion of spontaneous endothelial cell coverage on tissue valve prostheses |
| Q46959552 | Effect of erythropoietin administration on blood and plasma viscosity in hemodialysis patients. |
| Q67780259 | Effect of erythropoietin on neutrophil chemiluminescence in hemodialyzed patients |
| Q68644864 | Effect of extracorporeal membrane oxygenation on body water content and distribution in lambs |
| Q69658460 | Effect of intraperitoneal infusion volume and posture on left ventricular systolic function in patients on continuous ambulatory peritoneal dialysis |
| Q48923208 | Effect of long-term epoetin beta therapy on the quality of life of hemodialysis patients |
| Q69403887 | Effect of membrane characteristics on the performance of Couette rotating plasma separation devices |
| Q67819748 | Effect of nafamostat mesilate on bradykinin generation during low-density lipoprotein apheresis using a dextran sulfate cellulose column |
| Q50887308 | Effect of oxygen on isolated pancreatic tissue. |
| Q68978036 | Effect of plasma solute-membrane interaction on mean pore diameter |
| Q43465091 | Effect of polymeric albumin-IgG on blood-material interaction |
| Q68786097 | Effect of predialysis verapamil on intradialytic blood pressure in chronic hemodialysis patients |
| Q67780517 | Effect of pulsatile reperfusion on myocardial high energy phosphates following global ischemia |
| Q67780347 | Effect of recombinant human erythropoietin on vascular access |
| Q69440474 | Effect of red blood cells on platelet adhesion and aggregation in low-stress shear flow |
| Q69403889 | Effect of storage time on red blood cell membrane permeability to creatinine and uric acid |
| Q67780417 | Effect of synchronous and asynchronous pulsatile flow during left, right, and biventricular bypass |
| Q69403731 | Effect of varying dialysate bicarbonate concentration on serum phosphate |
| Q68644862 | Effective endothelialization of polyurethane surfaces. Response to shear stress and platelet adhesion |
| Q45286977 | Effectiveness of a counterpulsation device implanted on the ascending aorta |
| Q46110516 | Effectiveness of low dose erythropoietin: a possible advantage of high flux hemodialysis |
| Q69440397 | Effects of 25(OH)-vitamin D3 in hypocalcemic patients on chronic hemodialysis |
| Q44643946 | Effects of EPO therapy on backfiltration of dialysate in high flux dialysis |
| Q67780415 | Effects of Hemopump support on left ventricular unloading and coronary blood flow |
| Q69658465 | Effects of calcium channel blockers (verapamil, diltiazem) on peritoneal transport |
| Q67780244 | Effects of dialysis factors and route of administration on response of hemodialysis patients to recombinant human erythropoietin |
| Q69258816 | Effects of duration of acetylsalicylic acid administration on patency and anastomotic hyperplasia of ePTFE grafts |
| Q67780377 | Effects of long-term Novacor artificial heart support on blood rheology |
| Q68714593 | Effects of moderate hyperkalemia on the sinus node. Evaluation in anesthetized dogs |
| Q70228702 | Effects of nonpulsatile and pulsatile right ventricular bypass on pulmonary circulation |
| Q68622813 | Effects of prostaglandin I2, superoxide dismutase, and catalase on ischemia-reperfusion injury in liver transplantation |
| Q33865704 | Effects of recombinant human erythropoietin on T lymphocyte subsets in hemodialysis patients |
| Q41862879 | Effects of retrovenous myocardial drug delivery after coronary artery occlusion in sheep |
| Q69403885 | Effects of surface integrity on the fatigue life of thin flexing membranes |
| Q69403686 | Effects of zeta potential on the permeability of dialysis membranes to inorganic phosphate |
| Q68622710 | Efficacy of a biomechanical counterpulsation device powered by skeletal muscle for right heart assist |
| Q69403692 | Efficiency and biocompatibility of a polyethylene glycol grafted cellulosic membrane during hemodialysis |
| Q45101229 | Electric power induction through an isolated intestinal pouch |
| Q42121678 | Electrical control of intestinal reservoirs in a chronic dog model. |
| Q67780286 | Electrohydraulic ventricular assist device development |
| Q36904606 | Electronic pacing of incapacitated head and neck structures |
| Q68915295 | Electrophysiologic identification of the viability of a preserved heart in a hyperbaric chamber |
| Q47206995 | Elimination of low molecular weight proteins during hemoperfusion of dialysis patients using a urethane-sheet embedded with powdered charcoal |
| Q67977252 | Encapsulated thymic epithelial cells as a potential treatment for immunodeficiencies |
| Q39599728 | Encapsulated versus modified endocrine cells for organ replacement |
| Q68915305 | Endothelial cell growth factor attachment to biomaterials |
| Q69440472 | Endothelial cell seeding of ULTI carbon-coated small-diameter PTFE vascular grafts |
| Q68808717 | Endothelial cell-seeded artificial prostheses for coronary bypass grafting |
| Q68622830 | Endothelial injury during extracorporeal circulation. Role of the complement system |
| Q68622681 | Endothelialization of vascular prostheses by transplantation of venous tissue fragments |
| Q68622593 | Endothelialization on various segmented polyurethanes: cellular behavior and its substrate dependency |
| Q67780435 | Endothelin and platelet activating factor. Possible indices for biocompatibility of hemodialysis |
| Q67977215 | Enhanced albumin affinity of silicone rubber |
| Q70412687 | Enhanced bacterial adhesion on surfaces pretreated with fibrinogen and fibronectin |
| Q70319619 | Enzyme and drug delivery systems |
| Q69714861 | Enzyme-based electrochemical sensors |
| Q69440446 | Erythrocyte and granulocyte interactions with endothelialized polymer surfaces |
| Q45741667 | Erythrocyte deformability in patients on left ventricular assist systems. |
| Q67977096 | Erythropoietin alert: risks of high hematocrit hemodialysis |
| Q69626311 | Estimation of Lymphatic Absorption and Intraperitoneal Volume During Hypertonic Peritoneal Dialysis |
| Q34242732 | Estimation of Reynolds stresses within the Penn State left ventricular assist device |
| Q68389042 | Estimation of lymphatic absorption and intraperitoneal volume during hypertonic peritoneal dialysis |
| Q67977159 | Evaluation of Duraflo II heparin coating in prolonged extracorporeal membrane oxygenation |
| Q46949825 | Evaluation of Duraflo II heparin immobilized cardiopulmonary bypass circuits. |
| Q67977113 | Evaluation of a miniature blood glucose sensor |
| Q69658324 | Evaluation of a new antithrombogenic polyurethane-polysiloxane complex biomaterial |
| Q69658365 | Evaluation of a new vascular graft prosthesis fabricated from ultrafine polyester fiber |
| Q68202050 | Evaluation of a pyridoxylated hemoglobin-polyoxyethylene conjugate solution as a perfusate for liver preservation |
| Q67977122 | Evaluation of a rotating filter for use with therapeutic plasma exchange |
| Q48701415 | Evaluation of a stented polyurethane mitral valve prosthesis |
| Q68644869 | Evaluation of albumin loss during low-density lipoprotein apheresis |
| Q46605459 | Evaluation of compliant and noncompliant PTFE vascular prostheses |
| Q45997480 | Evaluation of dialyzers used in shortened dialysis. |
| Q67919003 | Evaluation of extracorporeal perfusion catheters using a standardized measurement technique--the M-number |
| Q68266776 | Evaluation of materials for use in extracorporeal circulation. In vitro serum-material interaction |
| Q69440466 | Evaluation of nonthrombogenic polymers in a new rabbit A-A shunt model |
| Q43816360 | Evaluation of plasma sodium concentration during hemodialysis by computerization of dialysate conductivity |
| Q43715181 | Evaluation of platelet damage in extracorporeal circuits using a visual platelet morphology method |
| Q69403819 | Evaluation of right ventricular function during clinical left ventricular assistance |
| Q69440501 | Evaluation of thrombogenesis on smooth and rough intima in artificial ventricles |
| Q43984398 | Events associated with rupture of intra-aortic balloon counterpulsation devices. |
| Q44148858 | Events following implantation of an intraluminal ringed prosthesis in the ascending, transverse, and descending thoracic aorta |
| Q67780436 | Evidence of mononuclear cell activation by hemodialysis |
| Q69559494 | Exchange blood transfusion and on-line plasma exchange for sepsis in infants |
| Q68488309 | Excitation thresholds for nerves reinnervating the paralyzed canine larynx |
| Q67780397 | Experience and directions using cardiopulmonary support in fifty-three consecutive cases |
| Q69626293 | Experience in reducing the hemolysis of an impeller assist heart |
| Q42077559 | Experience with an emergency resuscitation system |
| Q54209910 | Experience with the Sarns centrifugal pump as a ventricular assist device. |
| Q69658342 | Experimental chronic left ventricular failure in the dog |
| Q68622734 | Experimental development of a fixed volume, gravity draining, prosthetic urinary bladder |
| Q69403857 | Experimental evaluation and clinical application of a pediatric ventricular assist device |
| Q68368158 | Experimental evaluation of a heparin coated ECMO system simplified with a centrifugal pump |
| Q67780278 | Experimental evaluation of a new type of heparin-bonded polyurethane |
| Q70016308 | Experimental evaluation of extrapulmonary arterial balloon pumping (EPABP) for right heart failure of diverse etiologies |
| Q69440482 | Experimental model for LVAS evaluation under unphysiologic conditions |
| Q68622737 | Experimental studies of a hybrid artificial esophagus combined with autologous mucosal cells |
| Q69403644 | Experimental studies on an artificial esophagus for the purpose of neoesophageal epithelization using a collagen-coated silicone tube |
| Q70134871 | Experimental studies on an artificial trachea of collagen-coated poly(L-lactic acid) mesh or unwoven cloth combined with a periosteal graft |
| Q67780346 | Experimental studies on improved polyester-polyurethane vascular grafts for hemodialysis |
| Q67706525 | Experimental study of a new tracheal prosthesis made from collagen-grafted mesh |
| Q67780507 | Experimental study on limitations of anastomotic endothelialization of vascular prostheses |
| Q68202092 | Explant analysis of thirty-three bridge to transplant J7 total artificial heart devices |
| Q69403860 | Extended clinical support with an implantable left ventricular assist device |
| Q42042367 | Extended support with a left ventricular assist device as a bridge to heart transplantation |
| Q44659646 | External catheter immobilization improves wound healing in micropigs |
| Q44267429 | External peritoneo-venous shunt for intractable ascites. |
| Q70365716 | Extracorporeal CO2 removal (ECCO2R) improves oxygenation in a lung lavage model of acute respiratory failure |
| Q70365697 | Extracorporeal CO2 removal by hemodialysis in patients with chronic respiratory failure |
| Q126562120 | Extracorporeal Hybridization of Proximal Renal Tubular Cells and an Artificial Membrane for the Purpose of Beta2Microglobulin Removal |
| Q70228690 | Extracorporeal blood recirculation and beta-2-microglobulin plasma levels during hemodialysis |
| Q68812149 | Extracorporeal cellular immunotherapy |
| Q51778322 | Extracorporeal circulation in adult respiratory failure. |
| Q67819733 | Extracorporeal circulation in sheep with normal bleeding time using a surface heparinized circuit |
| Q68832367 | Extracorporeal circulatory assist devices |
| Q43855214 | Extracorporeal elimination of carbon dioxide using a surface-heparinized veno-venous bypass system |
| Q69559501 | Extracorporeal hybridization of proximal renal tubular cells and an artificial membrane for the purpose of beta 2 microglobulin removal |
| Q69015285 | Extracorporeal lipid extraction |
| Q51156649 | Extracorporeal membrane oxygenation as a means of stabilizing and transporting high risk neonates |
| Q69403874 | Extracorporeal membrane oxygenation for percutaneous coronary angioplasty in high risk patients |
| Q69440506 | Extracorporeal removal of iron with immobilized desferrioxamine |
| Q69658479 | Extracorporeal removal of tumor antigens |
| Q70134868 | Extracorporeal respiratory gas exchange: a look into the future |
| Q51767053 | Extracorporeal respiratory support in the adult. |
| Q43801284 | Extractable ethylene oxide from cuprammonium cellulose plate dialyzers: importance of potting compound |
| Q69658391 | Extraction of solute-free water from blood by membrane distillation |
| Q67780509 | Facilitation of endothelial cell growth on hydroxylated ePTFE vascular grafts |
| Q45226727 | Factors affecting morbidity and mortality during long-term short dialysis |
| Q69116017 | Factors associated with morbidity and mortality among patients on CAPD |
| Q69403848 | Factors contributing to oxalate deposits in the myocardia of hemodialysis patients |
| Q68020228 | Factors influencing acute thrombus formation on carotid artery vascular grafts |
| Q68622634 | Factors influencing the accuracy of the cardiac output monitoring and diagnostic unit for pneumatic artificial hearts |
| Q69403657 | Fall of cholesterol with time on dialysis: impact on atherogenicity |
| Q69714866 | Fiberoptic biosensors in artificial organs |
| Q67780274 | Fibronectin surface density affects endothelial cell function and growth on hydrophilic polymer |
| Q46581126 | Fine control of reinnervated muscle. Dynamic rehabilitation of facial paralysis |
| Q42035168 | First significant animal survival with a Wankel-type left ventricular assist device |
| Q36443886 | Flow cytometric study of immunocompetent cell phenotypes and phagocytosis in CAPD effluent |
| Q36438448 | Flow phenomena in compliant and noncompliant arteriovenous grafts |
| Q36438440 | Flow visualization in an artificial heart using diffuse and planar laser lighting |
| Q52495053 | Fluid shear disruption of cultured endothelium: the effect of cell species, fibronectin cross-linking and supporting polymer. |
| Q69403728 | Follow-up of reverse dextrose clearances in patients undergoing CAPD |
| Q70228706 | Forty-eight hour liver preservation using an artificial blood substitute |
| Q69658328 | Fracture healing with deferoxamine therapy in a patient with aluminum-associated osteomalacia |
| Q67780357 | Frequency and significance of infections in patients receiving prolonged LVAD support |
| Q68622703 | Functional heart replacement with the spindle pump: first results |
| Q70365687 | Functional properties of glutaraldehyde cross-linked Hb in the presence of CO2 and/or inositolhexaphosphate (IHP) |
| Q46177784 | Glomerulopressin in end-stage renal disease. Effect of hemodialysis |
| Q34583019 | Graft compliance and anastomotic flow patterns |
| Q70311555 | HDL-cholesterol sparing and APO-B removal in recycled cascade plasmafiltration |
| Q43424058 | Hand gangrene in diabetic patients on chronic dialysis |
| Q67780511 | Healing process of vascular prostheses seeded with venous tissue fragments |
| Q44385012 | Heart-mechanical assist device interaction |
| Q44003128 | Hematologic abnormalities and thromboembolic complications in calves implanted with pneumatic artificial hearts. Long-term studies and autopsy findings |
| Q69204528 | Hemodialysis for extracorporeal bicarbonate/CO2 removal (ECBicCO2R) and apneic oxygenation for respiratory failure in the newborn. Theory and preliminary results in animal experiments |
| Q69440383 | Hemodynamic adaptation to exercise after total artificial heart (TAH) implantation |
| Q41886865 | Hemodynamic and atrial natriuretic peptide responses to fluid removal and reinfusion in hemodialysis patients |
| Q43795527 | Hemodynamic and functional considerations of the Jarvik total artificial heart (TAH). |
| Q69626301 | Hemodynamic comparisons of polyurethane trileaflet and bioprosthetic heart valves |
| Q67977107 | Hemodynamic effects of a counterpulsation device implanted on the ascending aorta in severe cardiogenic shock |
| Q68622767 | Hemodynamic effects of a new right ventricular assist device |
| Q44808523 | Hemodynamic influence of LVAD on right ventricular failure. |
| Q44390536 | Hemofiltration and plasmapheresis in newborns using a small blood pump system |
| Q67977194 | Hemolysis. A comparative study of four nonpulsatile pumps |
| Q48941568 | Hemopump support for the failing heart |
| Q44659611 | Hemopump ventricular support for patients undergoing high risk coronary angioplasty |
| Q67780372 | Hemostatic evaluation of Sarns/3M-VAD implantation in calves |
| Q68786104 | Heparin free hemodialysis does not cause fibrin consumptive coagulopathy and maintains alternate pathway complement activation |
| Q69258842 | Heparin free long-term extracorporeal circulation using bioactive surfaces |
| Q69844096 | Heparin neutralization of antiplatelet effect of aspirin and dipyridamole |
| Q69403851 | Heparin-free hemodialysis with a polyacrylonitrile membrane |
| Q44841660 | High flux and cellulosic membranes. Biocompatibility and in vivo clearances. |
| Q39292385 | High seroprevalence of antibodies to human immunodeficiency virus in a Brooklyn maintenance hemodialysis unit: preliminary observations |
| Q46256950 | High venous urea concentrations in the opposite arm. A consequence of hemodialysis-induced compartment disequilibrium |
| Q69440511 | High-efficiency hemofiltration |
| Q69440444 | Human endothelial cell attachment receptors |
| Q68832363 | Humoral, cellular, and hemodynamic changes induced by blood-material interaction in membrane plasmapheresis |
| Q67780463 | Hybrid respiratory support system with extracorporeal placental oxygenation |
| Q68202035 | Hydrophilic high flux polyamide membranes for beta-2-microglobulin removal |
| Q69658349 | Idioperipheral pulsation during nonpulsatile biventricular bypass experiments |
| Q43978884 | IgE antibodies to isocyanates in hemodialyzed patients. |
| Q44928688 | Illness in hemodialysis patients after exposure to chloramine contaminated dialysate |
| Q69403622 | Imaging analysis of platelet deposition on the extracardiac valved conduit in humans |
| Q69403710 | Immobilized albumin-immunoglobulin G for improved hemocompatibility of biopolymers |
| Q68368169 | Immobilized carbonic anhydrase in a membrane lung for enhanced CO2 removal |
| Q69440503 | Immobilized desferrioxamine (DFO) for the extracorporeal removal of aluminum |
| Q46973215 | Immune response changes with blood pump use in calves |
| Q43656083 | Immunoadsorption of anti-A or anti-B antibody for successful kidney transplantation between ABO incompatible pairs and its limitation. Japanese Biosynsorb Research Group |
| Q69658441 | Implantable continuous intravenous insulin infusion device. Restoration of flow after slow-down |
| Q69440420 | Importance of membrane physicochemical properties on LDL/HDL separation |
| Q43763968 | Importance of ventricular arrhythmias in bridge patients with ventricular assist devices |
| Q67780536 | Importance of ventricular arrhythmias in recovery patients with ventricular assist devices |
| Q47376615 | Impotence. An historic perspective |
| Q68622654 | Improved biocompatibility by postfixation treatment of aldehyde fixed bovine pericardium |
| Q67780238 | Improved biocompatibility of bovine pericardium using a new method of cross linking |
| Q93529648 | Improved patient selection for TAH implantation |
| Q68622822 | Improved survival after Hemopump insertion in patients experiencing postcardiotomy cardiogenic shock during cardiopulmonary bypass |
| Q67977318 | Improved textured surfaces for implantable prostheses |
| Q69403697 | Improvement of peripheral circulation by low density lipoprotein adsorption |
| Q52423961 | Improvements in determination of cardiac output with a Swan-Ganz catheter. |
| Q68622631 | In vitro analysis of an atrial shunt in balancing an electrohydraulic total artificial heart |
| Q45829950 | In vitro and in vivo evaluation in dogs of a miniaturized glucose sensor |
| Q69403680 | In vitro and in vivo evaluation of a jellyfish valve for practical use |
| Q68622700 | In vitro and in vivo evaluation of a right ventricular assist device |
| Q69403738 | In vitro and in vivo performance evaluation of a totally implantable electrohydraulic left ventricular assist system |
| Q68622688 | In vitro and in vivo testing of a new valved intravascular catheter design |
| Q36438444 | In vitro and in vivo testing of a totally implantable left ventricular assist system. |
| Q46113863 | In vitro and in vivo testing of an electrocatalytic glucose sensor |
| Q44641898 | In vitro continuous wave Doppler gradients of mechanical valves in less than optimal orientations |
| Q69258875 | In vitro culture and transplantation of encapsulated human fetal islets as an artificial endocrine pancreas |
| Q67977279 | In vitro evaluation of a pyridoxalated hemoglobin polyoxyethylene conjugate in reversing cell sickling |
| Q46297741 | In vitro evaluation of a stentless porcine aortic bioprosthesis. A preliminary study |
| Q44340054 | In vitro flow characteristics of a new pump with a high inherent sensitivity to venous return |
| Q41275059 | In vitro low frequency electromagnetic field effect on fast axonal transport. |
| Q68434093 | In vitro model of endothelialization at anastomotic sites |
| Q44215043 | In vitro quantification of regurgitant jet flow by color Doppler ultrasound and conservation of momentum |
| Q68020221 | In vitro testing of bioprostheses |
| Q46136479 | In vitro testing of venous valves |
| Q44991281 | In vitro ultrasound characterization of a polyurethane trileaflet valve |
| Q69204520 | In vivo bicarbonate deficiency and insulin dissolution |
| Q67780385 | In vivo catecholamine extraction during continuous hemodiafiltration in inotrope-dependent patients |
| Q69403918 | In vivo determinants of energy consumption in electric motor driven artificial hearts |
| Q46363844 | In vivo evaluation of a peripheral vascular access axial flow blood pump |
| Q69658339 | In vivo evaluation of a permanently implantable thermal ventricular assist system |
| Q44264592 | In vivo evaluation of porous versus skinned polyurethane-polydimethylsiloxane small diameter vascular grafts |
| Q68622596 | In vivo nonthrombogenicity of heparin immobilized polymer surfaces |
| Q69403671 | In vivo performance of a transcutaneous energy transmission system with the Penn State motor driven ventricular assist device |
| Q69559497 | In vivo protein adsorption onto polymers: a transmission electron microscopic study |
| Q41973764 | In vivo results of hydrogel composite pericardial substitutes |
| Q68622669 | In vivo rheologic effects of lipid apheresis techniques: comparison of dextran sulfate LDL adsorption and heparin induced LDL precipitation |
| Q49133056 | In vivo solute extraction by a new polysulphone membrane with low ultrafiltration capacity |
| Q44607105 | Income and survival in chronic dialysis patients. |
| Q68622842 | Increase of intraplatelet free calcium ion during extracorporeal circulation with a hollow fiber oxygenator: arterial filter and dynamics of platelet thrombosis on oxygenator and filter in a pig model |
| Q43537335 | Increased vancomycin elimination with continuous hemofiltration |
| Q38641539 | Infections and thromboembolism with implantable cardiovascular devices |
| Q44638310 | Infectious complications associated with ventricular assist device support |
| Q69403684 | Inflammation as the possible cause of cystic radiolucencies in carpal bones of patients on hemodialysis |
| Q41428788 | Inflammatory response to implants |
| Q33293555 | Influence of centrifugal blood pumps on the elasticity of erythrocytes |
| Q68389011 | Influence of mold properties on surface structure of a polyurethane-siloxane block co-polymer. Implications for blood compatibility |
| Q68622803 | Influence of phosphatidylcholine on ultrafiltration and solute transfer in CAPD patients |
| Q69403716 | Influences of ventricular assist device pumping on blood coagulation |
| Q69658482 | Inhibition of bioprosthetic heart valve calcification by sustained local delivery of Ca and Na diphosphonate via controlled release matrices |
| Q70365720 | Inhibition of bioprosthetic heart valve calcification with covalently bound aminopropanehydroxydiphosphonate |
| Q69440476 | Initiation and growth of calcification in a polyurethane-coated blood pump |
| Q64970773 | Innovation in blood purification for hepatic failure: direct photoirradiation of plasma. |
| Q69658346 | Instrumentation for deriving pneumatic TAH control signals from the driveline pressure and flow |
| Q38641535 | Insulin delivery by implanted pump. A chronic treatment for diabetes. |
| Q70372815 | Insulin replacement: bionic or natural |
| Q68927154 | Insulin replacement: current concepts |
| Q70040951 | Interferon-gamma (IFN-gamma) as an in vitro enhancing factor of peritoneal macrophage defective bactericidal activity during continuous ambulatory peritoneal dialysis |
| Q42468558 | Interleukin-1 kinetics in hemodialysis |
| Q43461286 | Intestinal dialysis for kidney failure. Personal experience. |
| Q70134880 | Intra-aortic balloon counterpulsation in newborn lambs infected with group B streptococcus |
| Q44075191 | Intra-arterial carbacyclin infusion inhibits canine platelet deposition on PTFE grafts. |
| Q69440486 | Intra-right-atrial balloon pumping (IRABP) during a Fontan procedure |
| Q67977191 | Intraaortic balloon rupture |
| Q69929616 | Intracerebroventricular infusion of dopamine and its agonists in rodents and primates. An experimental approach to the treatment of Parkinson's disease |
| Q47316600 | Intradialytic parenteral nutrition in chronic hemodialysis patients |
| Q52237357 | Intraoperative determination of mediastinal constraints for a total artificial heart |
| Q70388613 | Intraperitoneal feeding |
| Q69506080 | Intraperitoneal insulin--a dose response curve |
| Q44923780 | Intraperitoneal therapy with interferon-alpha in CAPD patients with relapsing bacterial peritonitis |
| Q67977165 | Intraperitoneal verapamil therapy in CAPD patients with peritoneal hypopermeability. Effects on ultrafiltration |
| Q39274489 | Intravascular endoprostheses. Effect of surface geometry on restenosis and side branch patency |
| Q68020225 | Investigation of hemolytic anemia after chloramine exposure in a dialysis center |
| Q70016312 | Investigation of the flow in a centrifugal blood pump |
| Q44188377 | Ionic strength affects diffusive permeability to an inorganic phosphate ion of negatively charged dialysis membranes |
| Q67780212 | Is Na+ modeling necessary in high flux dialysis? |
| Q69658475 | Is air under the diaphragm a significant finding in CAPD patients? |
| Q70065289 | Is atrial natriuretic polypeptide a cause of pathophysiology in total artificial heart animals? |
| Q67780250 | Is hematologic response to iron and erythropoietin in hemodialysis patients affected by other factors? |
| Q70412692 | Is heparin necessary for extracorporeal circulation? |
| Q69714849 | Is one allowed to stop artificial organs, allowing patients to die? Opposing physicians' and philosophers' views |
| Q67780531 | Ischemic heart disease, serum cholesterol, and apolipoproteins in CAPD |
| Q67780205 | K & T covariate with V in hemodialysis. As K increases and T decreases, V also decreases |
| Q67977309 | Karyotype analysis of cell sex to determine the source of vascular graft luminal linings following autologous and nonautologous endothelial cell seeding |
| Q44904064 | Key issues for membranes used in hepatic assist |
| Q68020238 | Kinetic analysis of cholesterol removal by thermofiltration |
| Q69403702 | Kinetics and quantitation of In-111 labeled platelet deposition on control and heparin-bonded polyurethane angio catheters in a dog model |
| Q44013483 | Kinetics of collagen deposition within bioresorbable and nonresorbable vascular prostheses |
| Q52607837 | Kinetics of peritoneal dialysis with glycerol and glucose as osmotic agents. |
| Q45078739 | Kt/V and hemodialysis morbidity revisited. |
| Q52422896 | Kt/V: patients do not get what the physician prescribes |
| Q54293743 | LDL cholesterol apheresis by dextran sulfate cellulose adsorption. Long-term experience in patients with familial hypercholesterolemia |
| Q45048779 | LVAS pump performance following initiation of left ventricular assistance. |
| Q53758575 | Laboratory evaluation of a double lumen catheter for venovenous neonatal ECMO. |
| Q69658337 | Large-animal model of chronic congestive heart failure induced by intracoronary allylamine |
| Q69403634 | Laser vascular welding in biologic grafts |
| Q33285028 | Laser welding and irradiation in alcohol preserved homografts |
| Q36480537 | Laser welding of large diameter arteries and veins |
| Q45831924 | Late neutrophil infiltration of canine endothelial cell seeded Dacron grafts |
| Q42077557 | Left ventricular assist system with a simplified cannulation technique |
| Q68622769 | Left ventricular assist using a jet pump |
| Q63983791 | Left ventricular function in patients with centrifugal left ventricular assist device |
| Q67977146 | Left ventricular oxygen consumption and organ blood flow distribution during pulsatile ventricular assist |
| Q68622780 | Left ventricular versus left atrial cannulation for the Thoratec ventricular assist device |
| Q67780215 | Less symptomatic hypotension using blood volume controlled ultrafiltration |
| Q69626297 | Lessons gleaned from experience with artificial kidneys |
| Q68622662 | Leukocyte overshoot: a new sign of bioincompatibility in fast hemodialysis |
| Q34242961 | Light scattering detection of microemboli in an extracorporeal LVAD bovine model |
| Q46057252 | Limitation of myocardial infarct size by a right ventricular assist device |
| Q69403789 | Limitations of short dialysis are the indications for ultrashort daily auto dialysis |
| Q45015437 | Limulus amebocyte lysate reactivity, complement activation, and patients' symptoms. Comparison of dialyzer membranes |
| Q67977139 | Lipids in diabetic and nondiabetic hemodialysis and CAPD patients |
| Q67780495 | Liposome-embedded-heme as a totally artificial oxygen carrier |
| Q69658474 | Liposome-encapsulated hemoglobin as a red cell surrogate. Preparation scale-up |
| Q45151826 | Liquid nitrogen snap frozen saphenous vein for vascular access in dialysis |
| Q70412699 | Local controlled release of 1-hydroxyethylidene diphosphonate using silicone-rubber matrices. Effects of sterilization on in vitro release and in vivo efficacy |
| Q68202042 | Long-lived implanted silastic drum glucose sensors |
| Q57227147 | Long-term CaCO3 treatment of chronic hemodialysis patients: an attempt to prevent aluminum osteopathy |
| Q68360543 | Long-term Follow-up of Survivors of Postcardiotomy Circulatory Support |
| Q44243185 | Long-term anticalcification effect of Fe3+ in rat subdermal implants of glutaraldehyde preserved bovine pericardium. |
| Q69403837 | Long-term clinical experience with HELP-LDL-apheresis in combination with HMG-CoA-reductase inhibitors for maximum treatment of coronary heart disease associated with severe hypercholesterolemia |
| Q51770383 | Long-term closed chest partial and total cardiopulmonary bypass by peripheral cannulation for severe right and/or left ventricular failure, including ventricular fibrillation. The use of a percutaneous spring in the pulmonary artery position to deco |
| Q68622775 | Long-term echocardiographic follow-up of patients with a tricuspid bioprosthesis |
| Q43511385 | Long-term efficacy and safety of a low molecular weight heparin in chronic hemodialysis patients. A comparison with standard heparin |
| Q68622721 | Long-term efficacy of Al3+ for prevention of bioprosthetic heart valve calcification |
| Q69403666 | Long-term evaluation of a growable graft |
| Q68622752 | Long-term experience with Swan Neck Missouri catheters |
| Q39797779 | Long-term experience with routine single-needle dialysis. A review |
| Q69440429 | Long-term experience with the HELP system for treatment of severe familial hypercholesterolemia |
| Q70365708 | Long-term extracorporeal CO2 removal in sheep for up to 7 days using capillary fiber membrane oxygenators |
| Q67819731 | Long-term extracorporeal blood bypass in dogs at low flows without systemic heparinization. Heparin-coated versus uncoated circuits |
| Q43576851 | Long-term follow-up of patients on short-time dialysis |
| Q69440370 | Long-term follow-up study of survivors of postcardiotomy circulatory support |
| Q45109677 | Long-term hemofiltration in "poor risk" patients. |
| Q69258807 | Long-term in vivo study of gas diffusion in bilaminar compliance chambers |
| Q46066217 | Long-term outcome of continuous ambulatory peritoneal dialysis. The Southern California/Southern Nevada experience |
| Q30403780 | Long-term preservation of a beating heart in an artificial environment |
| Q69658311 | Long-term repetitive plasmapheresis in hypercholesterolemic rabbits |
| Q69403713 | Long-term results of a new antithrombogenic cardiac wall substitute |
| Q43657319 | Long-term stability of electroenzymatic glucose sensors implanted in mice. An update |
| Q68531927 | Long-term stability of implanted enzymatic biosensors |
| Q44810845 | Long-term survival with a pneumatic artificial heart |
| Q68368152 | Longitudinal survey of apolipoproteins and atherogenic risk in hemodialysis and continuous ambulatory peritoneal dialysis patients |
| Q69440441 | Low density lipoprotein accumulation by PTFE grafts in the rabbit aorta. Autoradiographic-morphologic correlations |
| Q68449863 | Low molecular weight heparin versus standard heparin. A long-term study in hemodialysis and hemofiltration patients |
| Q44075708 | Low-dose heparinization can be used with DEAE-cellulose hemodialysis membranes |
| Q44391664 | Lympho-monokine disorders and peritoneal fibroblast proliferation in CAPD. |
| Q68978033 | Macromolecular charge affects hemofilter solute sieving |
| Q39557496 | Macrophage-biomaterial interactions with bioresorbable vascular prostheses |
| Q68622716 | Maintenance of circulation during ventricular fibrillation with the simultaneous use of two "counterpulsation" devices |
| Q69658489 | Maintenance of compliance in a small diameter arterial prosthesis |
| Q68510656 | Maintenance of normoglycemia in pancreatectomized dogs with a controlled release micropump |
| Q67819724 | Management of postcardiotomy cardiogenic shock with a new pulsatile ventricular assist device. Initial clinical results |
| Q67780395 | Management of postoperative biventricular failure by means of a right ventricular assist device and an intraaortic balloon pump |
| Q52422893 | Mathematical modeling of erythropoietin therapy |
| Q68622847 | Maximum blood flow rates for arterial cannulae used in neonatal ECMO |
| Q35631945 | Mean flow velocity patterns within a ventricular assist device |
| Q33285047 | Mean velocities and Reynolds stresses within regurgitant jets produced by tilting disc valves |
| Q45074442 | Measurement of back clearance. |
| Q69403796 | Measurement of hemodialysis access recirculation: a two-needle method at the start of dialysis |
| Q67780225 | Measurement of peritoneal dialysate volume by CT |
| Q69440376 | Mechanical assistance in severe experimental cardiogenic shock |
| Q69403811 | Mechanical circulatory support for perioperative donor heart failure |
| Q67977287 | Mechanical evaluation of resorbable copolymers for end use as vascular grafts |
| Q69658356 | Mechanical factors influencing the durability of heart valve pericardial bioprostheses |
| Q69403892 | Mechanical failures of the pneumatic Utah-100 and Jarvik total artificial hearts. A comparative study |
| Q68020253 | Mechanical penile prostheses. The OmniPhase and DuraPhase designs |
| Q68622719 | Mechanical properties of basal and marginal mitral valve chordae tendineae |
| Q69403647 | Mechanism of dialysis-induced hypotension |
| Q47428356 | Membrane pore size and filtration selectivity in cryoglobulinemic plasma fractionation |
| Q69626288 | Metabolic alkalosis induced by regional citrate hemodialysis |
| Q44704014 | Method of pulmonary and membrane lung gas exchange measurement during extracorporeal membrane oxygenation |
| Q69403781 | Methods for volume assessment of an air filled compliance chamber |
| Q67780336 | Microbially infected thrombus in animals with total artificial hearts |
| Q69440389 | Microbiologic contamination of liquid bicarbonate concentrate for hemodialysis |
| Q69403895 | Microbiologic survey of prosthetic blood pumps presterilization and poststerilization and at explant retrieval |
| Q68915313 | Microencapsulated hepatocytes as a bioartificial liver |
| Q44488984 | Microencapsulated hepatocytes. Prospects for extracorporeal liver support |
| Q69564859 | Microencapsulation of pancreatic islets in a water insoluble polyacrylate |
| Q69440416 | Microencapsulation of parathyroid cells as a bioartificial parathyroid. In vitro studies |
| Q67780460 | Miniature membrane oxygenator for use in neonatal ECMO |
| Q69440469 | Minimum heparin release rate for nonthrombogenicity |
| Q69658439 | Minimum performance standards for double-lumen subclavian cannulas for hemodialysis |
| Q69440493 | Minimum power consumption of the electric ventricular assist device through the design of an optimal output controller |
| Q69440374 | Mode comparison study for a completely implantable TAH (CITAH) system |
| Q93529639 | Model of intestinal continence using an implantable pulse generator and a myoprosthetic sphincter |
| Q46231503 | Modeling urea kinetics with two vs. three BUN measurements. A critical comparison |
| Q70365701 | Modification of an ECCO2R system to improve CO2 removal at very low blood flow rates |
| Q70228730 | Modified cellulosic dialyzer membranes: an investigative tool in thrombogenicity studies |
| Q68488314 | Modulation of peritoneal macrophage antimicrobial activity by peritoneal dialysis fluid, Ca++, and 1,25(OH)2D3 in CAPD patients |
| Q67905170 | Molded double lumen silicone skin button for drivelines to an artificial heart |
| Q69119873 | Molecular understanding of cellular adhesion on artificial surfaces |
| Q68218167 | Moment in history. The Committee |
| Q68942142 | Moments in history. Introduction of left ventricular assistance |
| Q67819727 | Monitoring of factor XII activity and granulocyte elastase release during cardiopulmonary bypass |
| Q68434089 | Monitoring platelet interactions with prosthetic graft implants in a canine model |
| Q50552292 | Morbidity and mortality in hemodialysis patients. |
| Q68622864 | Multi-institutional evaluation of the Tokyo University Ventricular Assist System |
| Q69403814 | Multi-institutional studies of the National Cardiovascular Center Ventricular Assist System: use in 92 patients |
| Q69658470 | Multicenter evaluation of a bagless CAPD system |
| Q68202079 | Multiple regression analysis to identify factors important for maintaining insulin pump therapy |
| Q69403725 | Muscle powered circulatory assist device for diastolic counterpulsator |
| Q67977131 | Myocardial free fatty acid metabolism of the ischemic heart treated by left ventricular assist device |
| Q44032073 | Myocardial mechanics and energetics revisited |
| Q69403771 | Myocardial oxygen consumption. Comparison between left atrial pulsatile synchronous and asynchronous bypass |
| Q44185026 | Myocardial tolerance to ischemia after resuscitation. Direct mechanical ventricular actuation versus cardiopulmonary bypass |
| Q67780267 | Nafamostat mesilate administration during cardiopulmonary bypass decreases postoperative bleeding after cardiac surgery |
| Q36451663 | National experience with extracorporeal membrane oxygenation for newborn respiratory failure. Data from 715 cases |
| Q43942453 | National surveillance of dialysis-associated diseases in the United States, 1987. |
| Q40763659 | National surveillance of dialysis-associated diseases in the United States, 1988. |
| Q40750469 | National surveillance of dialysis-associated diseases in the United States, 1989 |
| Q69658413 | Natural heart recovery under left ventricular assist device pumping studied by echocardiography |
| Q70134896 | Near wall concentration profiles of 1.0 and 2.5 microns beads during flow of blood suspensions |
| Q67780370 | Neoendothelial healing of modified EPTFE grafts |
| Q41763736 | Neointima formation on an antithrombogenic cardiac wall substitute that can be reconstructed by host cells |
| Q39644725 | Neonatal ECMO. |
| Q67780391 | Neurologic improvement of patients with hepatic failure and coma during sorbent suspension dialysis |
| Q69844099 | Neutrophil behavior during hemodialysis. Role of membrane contact |
| Q50203077 | Neutrophil stimulation by lipid A and lipopolysaccharides from Salmonella minnesota |
| Q69403904 | New crisscross-shaped port design for universal serial pumps |
| Q39641515 | New graft materials and current approaches to an acceptable small diameter vascular graft |
| Q67977249 | New horizons in dynamic rehabilitation of paralyzed laryngeal functions |
| Q68714588 | New investigations of a pulsatile impeller blood pump |
| Q69403682 | New polyurethane valves in new soft artificial hearts |
| Q68808734 | New strategy for immunomodulation by ex vivo removal of an interleukin-2 inhibitor |
| Q38145074 | Nightly peritoneal dialysis. Why, who, how, and when? |
| Q34164511 | Nine year experience with the clinical use of total artificial hearts as cardiac support devices |
| Q51731535 | Non-heparin hemodialysis with oral administration of newly developed antiplatelet agent. |
| Q43917953 | Nondestructive analysis of mitral valve collagen fiber orientation |
| Q67977289 | Nondestructive evaluation by x-ray computed tomography of dialysate flow patterns in capillary dialyzers |
| Q70228721 | Nonpulsatile ventricular assist bridging to transplantation |
| Q52138548 | Nonsurgical implantation of a vascular ring prosthesis using thermal shape memory Ti/Ni alloy (Nitinol wire). |
| Q68622706 | Novacor left ventricular assist filling and ejection in the presence of device complications |
| Q52097700 | Novel airway stent using a thermal shape-memory Ti-Ni alloy |
| Q54728140 | Novel mechanical assistance in the treatment of endotoxic and septicemic shock. |
| Q68622589 | Novel photoreactive surface modification technology for fabricated devices |
| Q69440477 | Nutritional assessment of continuous ambulatory peritoneal dialysis patients |
| Q41897133 | Nutritional assessment of patients with extended left ventricular assist device support |
| Q70228713 | On the impact of and need for chronic dialysis and renal transplantation |
| Q68622853 | One year of rHuEPO therapy prolongs RBC survival and may stabilize RBC membranes despite natural progression of chronic renal failure to uremia and need for dialysis |
| Q44130252 | One year's experience using a rotating filter for therapeutic plasma exchange |
| Q67977293 | Optical sensor for hemoglobin content and oxygen saturation. Application to artificial heart research |
| Q67780427 | Optimal dialysate bicarbonate during hemodialysis |
| Q67977178 | Optimal timing for application of ventricular assist devices in patients who cannot be weaned from cardiopulmonary bypass. An experimental study |
| Q41959363 | Optimization of pacing parameters for conditioned latissimus dorsi muscle in cardiomyoplasty |
| Q68622858 | Oral anticoagulation in patients with ventricular assist devices |
| Q70242927 | Orthotopic liver transplantation for fulminant and subacute hepatic failure |
| Q67977238 | Osmotic disequilibrium causing ascites during chronic hemodialysis |
| Q67780423 | Outcome of cardiopulmonary resuscitation in patients on chronic dialysis |
| Q69403865 | Oxalate crystal deposits in renal tubules and cystic changes in 5/6 nephrectomized and normal rats |
| Q69440414 | Oxygen transport by a pyridoxalated-hemoglobin-polyoxyethylene conjugate |
| Q51807442 | P-450 activity in monolayer cultures of hepatocytes seeded in polystyrene tissue culture dishes. |
| Q68832372 | PMN C5a-receptor down regulation is not involved in recovery from C5a-induced neutropenia |
| Q69658359 | PTFE-silicone self-sealing dialysis prosthesis |
| Q45138443 | Palliative treatment of bile duct tumoral compression by an endoprosthesis: clinical results |
| Q68202024 | Pathogenesis of acquired renal cysts in hemodialysis patients. The role of oxalate crystal deposition in renal tubules |
| Q38641548 | Pathogenesis of ascites in cirrhosis. A unitary hypothesis |
| Q38004801 | Patterns of bacterial infection in calves implanted with artificial hearts. |
| Q39557513 | Pediatric ECMO. Directions for new developments |
| Q69658459 | Peptides as substitute osmotic agents for glucose in peritoneal dialysate |
| Q69440396 | Percent reduction in blood urea concentration during hemodialysis (PRU). A simple and accurate method to estimate Kt/V urea |
| Q68020232 | Percutaneous access for peritoneal dialysis |
| Q38480810 | Percutaneous cardiopulmonary bypass to support angioplasty and valvuloplasty. Technical considerations |
| Q44112854 | Percutaneous cardiopulmonary support in cardiac arrest |
| Q67780419 | Percutaneous transluminal coronary angioplasty with hemoperfusion |
| Q43592189 | Percutaneous venous angioplasty in the treatment of stenotic lesions affecting dialysis fistulas |
| Q67780263 | Performance evaluation of hydroxylated and acylated silicone rubber coatings |
| Q45940301 | Performance of a longitudinally compliant PTFE vascular prosthesis in an ovine A-V fistula model. |
| Q69403833 | Performance of a new hybrid artificial liver support system using hepatocytes entrapped within a hydrogel |
| Q69403639 | Performance of a new vascular xeno prosthesis |
| Q44970512 | Perineural leads and burst stimulation optimize contraction of skeletal muscle |
| Q69403843 | Periodic elevation of complement activation products in peritoneal dialysis effluent |
| Q33285075 | Peripheral circulation during nonpulsatile systemic perfusion in chronic awake animals |
| Q68488306 | Peripheral nerve regeneration through a novel bioresorbable nerve guide |
| Q39489188 | Peritoneal catheter development. Currently used catheters--advantages/disadvantages/complications, and catheter tunnel morphology in humans. |
| Q67977171 | Peritoneal clearances. Long-term study |
| Q69658277 | Peritoneal dialysis |
| Q68389020 | Peritoneal dialysis for acute renal failure |
| Q67708151 | Peritoneal fluid kinetics during CAPD measured with intraperitoneal dextran 70 |
| Q43924173 | Peritoneal macrophage beta-2 microglobulin production and bacterial peritonitis in CAPD patients |
| Q52543847 | Peritoneal oxygenation of normoxic and hypoxic dogs. |
| Q54763419 | Peritoneal sclerosis. Role of plasticizers. |
| Q41311880 | Peritoneovenous shunt function 2-6 years after insertion for cirrhotic ascites |
| Q44612467 | Peritoneovenous shunts in the management of ascites |
| Q68020235 | Permanently implanted devices for drug infusion |
| Q67977228 | Permeability decay in CAVH hemofilters |
| Q69658300 | Permeation rate to oxygen of membrane tympanostomy tubes |
| Q69559504 | Pharmacodynamics of FUT-175 anticoagulant in adsorbent plasma perfusion |
| Q70134861 | Pharmacokinetics of gentamicin in neonatal patients supported with extracorporeal membrane oxygenation |
| Q68622797 | Phenotypic characterization of monocytes and macrophages from CAPD patients |
| Q46275147 | Phosphatase enzyme activity is retained in glutaraldehyde treated bioprosthetic heart valves. |
| Q67780502 | Phosphate removal during hemodialysis, hemodiafiltration, and hemofiltration. A reappraisal |
| Q69403642 | Photochromic visualization for investigation of artificial heart valves |
| Q43626812 | Physiologic effects of pyridoxalated-hemoglobin-polyethylene glycol conjugate solution in exchange transfusion. |
| Q51731530 | Physiologic reactions of awake animals to an immediate switch from a pulsatile to nonpulsatile systemic circulation. |
| Q54135392 | Physiologic role of enhanced fibrinolytic activity during cardiopulmonary bypass in open heart surgery. |
| Q69440435 | Piezoelectric nerve guidance channels enhance peripheral nerve regeneration |
| Q67780497 | Placement of aortic valve bioprostheses in sheep via a left thoracotomy. Implantation of stentless porcine heterografts |
| Q69403653 | Plasma histamine levels and kinetics in chronic hemodialysis patients |
| Q67977233 | Plasma perfusion in myasthenia gravis |
| Q43962705 | Plasma protein and gelatin surface interactions. Kinetics of protein adsorption |
| Q69626309 | Plasma retention and metabolic fate of hemoglobin modified with an interdimeric covalent cross link |
| Q67780457 | Plasma water filtration and lymphatic uptake during peritoneal dialysis |
| Q67780342 | Platelet deposition on polyethylene. Dependence of second layer platelet attachment on von Willebrand's disease plasma |
| Q69403827 | Platelet interactions with heparin binding growth factor and fibronectin |
| Q41140801 | Platelet preservation during cardiopulmonary bypass with iloprost and Duraflo-II heparin-coated surfaces |
| Q69440411 | Platelet reactions with artificial surfaces |
| Q69440354 | Polarization and adsorption effects on sieving in membrane protein filtration |
| Q69440399 | Polymethylmethacrylate in chronic hemodialysis. Is it of benefit in patients with uremic neuropathy? |
| Q93529655 | Polymorphonuclear cell phagocytosis and surface receptor modulation after extracorporeal circulation |
| Q39557489 | Polyurethane small artery substitutes. |
| Q47444848 | Pore size and temperature effects in membrane separation of albumin from immunoglobulins |
| Q47172413 | Post to predialysis plasma urea nitrogen ratio, ultrafiltration and weight to estimate K.t/V. Use in auditing the amount of dialysis being administered |
| Q69440454 | Potential bacteriologic and endotoxin hazards associated with liquid bicarbonate concentrate |
| Q52460581 | Power capability of skeletal muscle to pump blood. |
| Q46420990 | Practical assessment of natural heart function using echocardiography in mechanically assisted patients |
| Q67977183 | Predictive control by physical activity rate of a total artificial heart during exercise |
| Q68360547 | Predictors for weaning patients from ventricular assist devices |
| Q43899291 | Predictors for weaning patients from ventricular assist devices (VADs). |
| Q69658496 | Preliminary experience with the Swan Neck peritoneal dialysis catheters |
| Q67780203 | Preliminary in vitro evaluation of the first neonatal total artificial heart |
| Q69844102 | Preparation of bacteriologically safe bicarbonate concentrate for hemodialysis |
| Q54391618 | Present status of human cardiac allografts and prospects for xenografts. |
| Q69440514 | Presidential address. Innovation and maturity |
| Q68622747 | Pressure effects on roller pump blood flow during hemodialysis |
| Q69403741 | Pressure indices of myocardial oxygen consumption during pulsatile ventricular assistance |
| Q44859062 | Prevalence of HIV virus among patients undergoing continuous ambulatory peritoneal dialysis |
| Q68622739 | Prevention of infection in a porous tracheal prosthesis by omental wrapping |
| Q69440418 | Prevention of thrombosis-related complications in cardiac catheterization and angiography using a heparinized catheter (Anthron) |
| Q68622786 | Prognosis of hospital survivors after salvage from cardiopulmonary bypass with centrifugal cardiac assist |
| Q68622878 | Proliferation and substrate effects on endothelial cell thrombogenicity |
| Q67780483 | Prolongation of cardiac xenograft function after reduction of natural antibodies using double filtration plasmapheresis |
| Q67977299 | Prolonged extracorporeal membrane oxygenation in sheep with a hollow-fiber oxygenator and a centrifugal pump |
| Q45104990 | Prophylactic administration of tranexamic acid preserves platelet numbers during extracorporeal circulation in rabbits |
| Q44231585 | Prospective comparison of peritoneoscopic and surgical implantation of CAPD catheters |
| Q46857798 | Prostaglandin E2, thromboxane B2, and leukotriene B4 release from peritoneal macrophages by different osmotic agents in nonuremic guinea pigs |
| Q68808738 | Prostaglandin production and extracorporeal complement activation by dialyzer membranes |
| Q67780366 | Prostatic titanium urethral stents. A new treatment option for obstructive uropathy: early clinical results and indications |
| Q67780311 | Protamine-coated Cuprophan. A potential nonthrombogenic hemodialysis membrane with improved blood compatibility |
| Q51731525 | Protection of the small intestine against irradiation by means of a removable prosthesis. |
| Q67780453 | Protein catabolic rate calculations in CAPD patients |
| Q44704976 | Pulmonary artery counterpulsation with a skeletal muscle power source |
| Q70065290 | Pulmonary emboli from blood-biomaterial interaction |
| Q67780381 | Pulsatile flow and EC morphology in a VAD-like chamber |
| Q69440433 | Pump-induced hemolysis in a rabbit model of neonatal ECMO |
| Q44034632 | Pumping capabilities of the latissimus dorsi and rectus abdominis muscles wrapped around a valved pouch in a mock circulatory system. |
| Q67780473 | Quality of life in long-term survivors of the Hemopump left ventricular assist device |
| Q69658323 | Quantitation of platelet and fibrinogen deposition on PTFE and vein grafts in dogs and the effect of vitamin E on graft thrombosis in the acute phase |
| Q53716405 | Quantitation of platelet and fibrinogen-fibrin deposition on components of tissue valves (Ionescu-Shiley) in calves. |
| Q33422827 | Quantitation of platelet loss with indium-111 labeled platelets in a hollow-fiber membrane oxygenator and arterial filter during extracorporeal circulation in a pig model. |
| Q67780470 | Quantitative gas transfer into and out of circulating venous blood by means of an intravenacaval oxygenator |
| Q67977217 | Quantitative scanning electron microscopy for the evaluation of thrombosis in extracorporeal circuits |
| Q43692369 | Racial differences in renal transplant outcome of insulin-dependent diabetic recipients in the cyclosporine era |
| Q67919001 | Randomized clinical trials |
| Q38641581 | Randomized clinical trials of treatment of ascites in alcoholic cirrhotics. Medical treatment versus peritoneovenous shunting. |
| Q68622838 | Rapid and precise whole blood protamine titration |
| Q68978028 | Rapid assay for heparin during extracorporeal circulation |
| Q69658385 | Rapid blood flow short dialysis does not adversely affect clinical, biochemical, or nutritional status of patients |
| Q69658314 | Rapid high-efficiency bicarbonate hemodialysis |
| Q69440391 | Rapid improvement of uremic neuropathy on short high-efficiency hemodialysis with special reference to middle molecules |
| Q68622695 | Rapid methods of estimating Kt/V: three formulas compared |
| Q42030563 | Rapid platelet separation and collection for postoperative autologous transfusion |
| Q39292391 | Real time sound spectral analysis for diagnosis of thrombosed prosthetic valves. |
| Q41980421 | Real time sound spectral analysis for early detection of thrombosed Björk-Shiley standard disc valves |
| Q67780406 | Real-time in vitro observation of cavitation in a prosthetic heart valve |
| Q69403656 | Reasonably short hemodialysis time can be achieved without ultra-high efficiency dialyzers and without ultrafiltration-controlled delivery systems |
| Q38754920 | Recent efforts in artificial heart research in Czechoslovakia |
| Q38737596 | Recombinant human erythropoietin correction of anemia. Dialysis efficiency, waste retention, and chronic dose variables |
| Q68622889 | Recombinant human erythropoietin does not increase clotting in vascular accesses |
| Q67780293 | Reconstructed image of the human heart based on magnetic resonance images for total artificial heart implantation |
| Q64129571 | Recovery of bacteria from reprocessed high flux dialyzers after bacterial contamination of the header spaces and O-rings |
| Q43960231 | Recovery of end-stage organ dysfunction by circulatory assist |
| Q44205766 | Recurrent venous thrombosis associated with permanent internal jugular vein hemodialysis catheters |
| Q67977313 | Red blood cell effect on platelet adhesion and aggregation in low-stress shear flow. Myth or fact? |
| Q44916911 | Red blood cell membrane permeability of uremic and normal cells |
| Q69658369 | Reduced platelet adhesion and activation of coagulation factors on polyurethane treated with albumin-IgG complex |
| Q41265851 | Reducing the variability in durability of heart valve bioprostheses. Key factor for future improvement |
| Q43805041 | Reduction in aluminum load after one year of hemodiafiltration |
| Q70412684 | Reduction of the antigenicity and immunogenicity of xenografts by a new cross-linking reagent |
| Q69658417 | Regeneration of transected sciatic nerves through semi-permeable nerve guidance channels. Effects of extracellular matrix protein additives |
| Q69403871 | Regional blood flow during extracorporeal membrane oxygenation in lambs |
| Q69440404 | Regional heparinization for continuous arterio-venous hemofiltration (CAVH) |
| Q69440372 | Registry and tabulations of orthotopic total artificial hearts in humans |
| Q69403749 | Regulation of coronary circulation during left ventricular assist |
| Q52632728 | Relationship between Staverman's reflection and sieving coefficients in a plasma fractionator. |
| Q43899593 | Relationship between phagocyte metabolic function and years of maintenance dialysis |
| Q69440393 | Relationship between sympathetic dysfunction and hemodialysis instability |
| Q43861326 | Removal and prevention of resynthesis of lymphocytotoxic antibodies by plasma exchange prior to cardiac transplantation. |
| Q69658447 | Removal of aluminum from chronic dialysis patients by administration of desferrioxamine and dialysis |
| Q43558363 | Removal of antibodies with immunoadsorption from an ABO incompatible recipient prior to renal transplant |
| Q70228726 | Removal of beta-2-microglobulin by diffusion alone is feasible using highly permeable dialysis membranes |
| Q68202085 | Removal of beta-2-microglobulin by direct hemoperfusion with a newly developed adsorbent |
| Q67819740 | Renal allograft outcome in the cyclosporine era: comparison between intermediate-term failure and long-term survival |
| Q41249804 | Renal biofiltration |
| Q67977124 | Renal effects of a pyridoxalated-hemoglobin-polyoxyethylene conjugate solution as a blood substitute in exchange transfusions |
| Q69440516 | Renal epithelial cells grown on semipermeable hollow fibers as a potential ultrafiltrate processor |
| Q68202069 | Renal failure in patients with ventricular assist devices |
| Q69440459 | Renal insufficiency and volume overload in neonatal ECMO managed by continuous ultrafiltration |
| Q69559503 | Renal transplantation: results in hemodialysis patients previously treated with recombinant human erythropoietin |
| Q68915310 | Renin-aldosterone response and systemic blood pressure in long-term anephric patients on hemodialysis |
| Q68360551 | Report from the International Study Group on Implantable Insulin Delivery Devices |
| Q69403901 | Residence time distributions in artificial ventricles |
| Q69844108 | Resorbable structured porous materials in the healing process of hard tissue defects |
| Q70365694 | Respiratory gas exchange using hemodialysis and an O2 carrier |
| Q43571507 | Response of CAPD patients with a high incidence of peritonitis to intraperitoneal immunoglobulin therapy |
| Q41405456 | Response of complement and neutrophils to hydrophilized synthetic membranes |
| Q67780448 | Response of continuous peritoneal dialysis patients to subcutaneous recombinant human erythropoietin differs from that of hemodialysis patients |
| Q67977149 | Restoration and maintenance of intravenous insulin infusion in the vapor-pressure powered implantable infusion device |
| Q69258824 | Retroperitoneal feeding tube for peritoneal dialysis patients |
| Q67819752 | Reuse of "highly permeable" dialyzers with peroxyacetic acid as sole cleansing and disinfecting agent |
| Q68202061 | Rheologic abnormalities in patients with the Jarvik-7 total artificial heart |
| Q67977282 | Rifampin activity against Staphylococcus epidermidis biofilms |
| Q54404306 | Right heart assist for acute right ventricular failure after orthotopic heart transplantation. |
| Q69658352 | Right ventricular end-systolic pressure-dimension relationship during left ventricular bypass in anesthetized pigs |
| Q69403822 | Right ventricular failure during clinical use of a left ventricular assist device |
| Q67977297 | Right ventricular perfusion and heparin bonding of a cross-flow membrane oxygenator |
| Q68622646 | Right-left ventricular balance in implanted electrically powered artificial hearts |
| Q43846415 | Role of catheter removal in therapy of bacterial peritonitis of continuous ambulatory peritoneal dialysis |
| Q60924986 | Role of von Willebrand factor in platelet interaction with an expanded PTFE surface |
| Q68714578 | Roll up your sleeves, spit in your hands--there is still much to do in dialysis of the elderly |
| Q69658411 | Roller screw electric motor ventricular assist device |
| Q68622642 | Rotacor: a new rotary blood pump |
| Q54380863 | Rotation-induced Taylor vortex enhances filtrate flux in plasma separation. |
| Q51710183 | Routine extracorporeal circulation with a centrifugal or roller pump |
| Q67780222 | SPUU-PEO-heparin graft copolymer surfaces. Patency and platelet deposition in canine small diameter arterial grafts |
| Q67780524 | Safe and effective plasma exchange to remove antibodies prior to xenogeneic heart transplantation in small primates |
| Q68622605 | Safety, stability, and effectiveness of immunoadsorption under membrane plasmapheresis treatment for myasthenia gravis |
| Q69440426 | Salvage of ischemic myocardium by retrograde venous perfusion |
| Q46968896 | Scanning and transmission electron microscopic evaluation of the U-100 total artificial heart blood contacting surface |
| Q70134857 | Seldinger technique for Tenckhoff catheter placement |
| Q34661543 | Selective continuous elimination of low density lipoproteins (LDL) by heparin precipitation: first clinical application |
| Q69440423 | Selective removal of high level cryoglobulins (CG) and immune complexes (IC) by a large pore membrane |
| Q43887416 | Sensitivity of the Azure heparin assay and comparisons with activated clotting time and whole blood partial thromboplastin time |
| Q52470912 | Sensitivity of the artificial heart to changes in vascular resistance. |
| Q48701400 | Sensory perception in uremic patients |
| Q67780374 | Serum silicon levels in recipients of an electrohydraulic ventricular assist system |
| Q67993312 | Serum sulfate concentration and the anion gap in hemodialysis patients |
| Q69403674 | Shear stress affects expression of major histocompatibility complex antigens on human endothelial cells |
| Q41728870 | Shear stress induces not only platelet aggregation but also platelet-tumor cell interaction |
| Q43623822 | Short hemodialysis--10-year follow-up. |
| Q69658302 | Short-term in vivo operation of a glucose sensor |
| Q68622581 | Shortening of the hemodialysis procedure and mortality in "healthy" dialysis patients |
| Q39557502 | Should AIDS patients be dialyzed? |
| Q68915283 | Should vitamin C supplementation be restricted in regular hemodialysis patients? |
| Q69440351 | Significance of hepatic assist by plasma exchange. With special reference to host defense mechanisms |
| Q69403736 | Significance of various anticoagulation therapies during use of a left ventricular assist device |
| Q68202027 | Silicon in chronic hemodialysis patients |
| Q70365674 | Simplified bypass for cardiogenic shock |
| Q67977260 | Simplified method of hemofiltration in ventricular assist device patients |
| Q67780522 | Simultaneous heparin extracorporeal LDL precipitation and hemodialysis. First clinical experience |
| Q68142776 | Single catheter veno-venous membrane lung bypass in the treatment of experimental ARDS |
| Q70365705 | Single catheter venous-venous membrane lung bypass in the treatment of experimental ARDS |
| Q67977109 | Skeletal muscle ventricles as a potential right heart assist or substitute |
| Q67819745 | Skeletal surveys in renal osteodystrophy |
| Q68389028 | Slow continuous hemodialysis |
| Q68389040 | Slow continuous hemofiltration and slow continuous ultrafiltration |
| Q41265818 | Small diameter vascular prostheses. |
| Q44157896 | Soft artificial ventricles for infants and adults, with or without a clamshell. |
| Q69714853 | Solid-state transducers for biomedical applications |
| Q47428374 | Spherical rotary piston machine as an artificial heart |
| Q69403840 | Splanchnic volume, not flow rate, determines peritoneal permeability |
| Q67977208 | Stability and immunologic activity of immobilized heparinase and bilirubin oxidase |
| Q67780227 | Staphylococcus epidermidis biofilms: unexpected outcome of double and triple antibiotic combinations with rifampin |
| Q39544506 | State of the art. Circulatory support |
| Q68622665 | Sterile versus non-sterile dialysis fluid in chronic hemodialysis treatment |
| Q68531932 | Sterilization of biosensors |
| Q69658284 | Strontium overload in uremic patients on regular dialytic treatment |
| Q69403768 | Study of heat dissipation to the lung from a thermal ventricular assist system |
| Q70311558 | Study of platelet function in a calf with artificial ventricles attached to an ex vivo shunt |
| Q68622880 | Substrate effects on endothelial cell adherence rates |
| Q69559507 | Successful immunoadsorption with membrane plasmapheresis for multiple sclerosis |
| Q67977245 | Successful long-term use of a miniaturized plasmapheresis circuit in rabbits |
| Q43547016 | Sulfation and glucuronidation of acetaminophen by cultured hepatocytes replicating in vivo metabolism. |
| Q67977222 | Superiority of selective bolus infusion and simultaneous rapid removal of anticancer agents by charcoal hemoperfusion in cancer treatment |
| Q67977119 | Supplemental insulin delivery from an implanted reservoir activated by external compression |
| Q67977155 | Suppression mechanisms for thrombus formation on heparin-immobilized segmented polyurethane-ureas |
| Q68622896 | Suppression of immunoglobulin and interleukin-6 production from peripheral blood mononuclear cells by dialysis membranes |
| Q68266780 | Suppression of the natriuretic effects of exogenous atrial natriuretic peptide in animals with total artificial hearts |
| Q67676500 | Surface induced in vitro angiogenesis: surface property is a determinant of angiogenesis |
| Q52250021 | Surgical implantation of the artificial urinary sphincter. |
| Q69403765 | Sustained heart failure induced by repeated microsphere injections for left ventricular assist device testing |
| Q67977291 | Synthetic vascular graft fabrication by a precipitation-flotation method |
| Q69047785 | Systemic and local effects of heat dissipation in the thermally powered LVAS |
| Q61662598 | Technical and clinical evaluation of a new system for ultrafiltration control during hemodialysis |
| Q68389036 | Technical aspects of continuous and intermittent therapies |
| Q44369437 | Technical aspects of plasma leakage prevention in microporous capillary membrane oxygenators. |
| Q69440455 | Technical requirements for rapid high-efficiency therapy in uremic patients. Paired filtration-dialysis (PFD) with a two-chamber technique |
| Q69403784 | Technology and long-term application of an epineural electrode |
| Q46788848 | Temperature dependence of macromolecular sieving across plasma fractionating membranes. |
| Q69403835 | Temperature dependent protein removal by large pore membrane filtration |
| Q51770386 | Temporary liver support using a new type of sorbent. A urethane sheet embedded with powdered charcoal. |
| Q69714844 | Temporary mechanical support for cardiogenic shock |
| Q67977116 | Temporary metabolic support by extracorporeal blood therapy for liver failure after surgery |
| Q41337523 | Temporary ventricular support. Current indications and results |
| Q64113026 | The 1987 USA National CAPD Registry Report |
| Q69658455 | The CAPD peritonitis rate is not improving with time |
| Q38641564 | The Minnesota shunt |
| Q52486540 | The Mitroflow pericardial valve. First five years of follow-up evaluation. |
| Q42042463 | The anion gap of patients receiving bicarbonate maintenance hemodialysis |
| Q41349969 | The artificial heart--1986: partial fulfillment of a promise |
| Q70242914 | The artificial urinary sphincter |
| Q68531919 | The biocompatibility of artificial organs |
| Q41930157 | The birth of the new idea called "prophylactic daily dialysis" for the treatment of acute renal failure |
| Q69440431 | The calf as a model for thromboembolic events with the total artificial heart |
| Q34242966 | The closing velocity of Baxter Duromedic heart valve prostheses |
| Q44442455 | The coming generation of new small vascular grafts |
| Q45242056 | The composite Corethane/Dacron vascular prosthesis. Canine in vivo evaluation of 4 mm diameter grafts with 1 year follow-up |
| Q42099608 | The consequence of ventricular assist on acute profound biventricular failure with induced severe myocardial injury |
| Q67780409 | The correlation between improved cellular viability and clinical performance in 5,000 cryopreserved human heart valves |
| Q67780515 | The development of a clinically relevant canine model of postperfusion syndrome |
| Q68622885 | The dynamics of platelet thrombus formation rate, thrombus retention time, and rate of embolization on a control and heparin bonded polyurethane angio-catheter |
| Q67977198 | The effect of cooled dialysate on thermal energy balance in hemodialysis patients |
| Q69403695 | The effect of extracorporeal cholesterol removal on the progression of atherosclerosis |
| Q46455178 | The effect of graded exercise on cardiac output of the Jarvik-7-70 total artificial heart in humans |
| Q45004353 | The effect of heparin on three whole blood activated clotting tests and thrombin time. |
| Q69658335 | The effect of left ventricular assistance on the area of infarcted myocardium |
| Q69403663 | The effect of neutrophil depletion on reperfusion arrhythmias during intracoronary thrombolysis using the leukocyte removal filter |
| Q39295150 | The effect of porosity and biomaterial on the healing and long-term mechanical properties of vascular prostheses. |
| Q68622651 | The effect of protamine on antibiotic action against Staphylococcus epidermidis biofilms |
| Q67780218 | The effect of surface hydrophilicity on biomaterial-leukocyte interactions |
| Q67977316 | The effect of suture material on platelet deposition onto prosthetic material |
| Q52422895 | The effect of ultrafiltration on dialysance. Mathematical theory and experimental verification |
| Q50894001 | The effects of anticalcification treatments on bioprosthetic heart valves implanted in sheep. |
| Q43592633 | The failure of home hemodialysis. |
| Q68622794 | The force of detachment of endothelial cells from different solid surfaces |
| Q41265833 | The future of bioprosthetic valves. |
| Q39557481 | The future of bioprosthetic valves. A pathologist's perspective |
| Q67977091 | The health of ASAIO: shadows cast into the 21st century |
| Q68808728 | The importance of a patent foramen ovale in left ventricular assist pumping |
| Q61662603 | The importance of ultrafiltration on acid-base status in a dialysis population |
| Q69403913 | The incidence of isolated left ventricular failure in bridge-to-transplant candidates |
| Q68020252 | The inflatable penile prosthesis |
| Q68644867 | The influence of dialysate sodium and variable ultrafiltration on fluid balance during hemodialysis |
| Q41144427 | The influence of dialysis membrane upon protein catabolic rate |
| Q43646811 | The influence of dialysis treatment modality on the decline of remaining renal function |
| Q67918999 | The inhibition of calcification of bioprosthetic heart valves by Al and Fe pretreatment |
| Q43457468 | The introduction of continuous ambulatory peritoneal dialysis (circa 1975). |
| Q34190358 | The microscopic evaluation of skin buttons used in a long-term human total artificial heart recipient. |
| Q70242921 | The minimal importance of the hollow viscera to peritoneal transport during peritoneal dialysis in the rat |
| Q68644859 | The need for intensive study of pericardial substitution after open heart surgery |
| Q44323487 | The newly designed univalved artificial heart |
| Q41992227 | The peritoneoscopic implantation of a polyurethane percutaneous access device for peritoneal dialysis. Preliminary experience |
| Q37923475 | The peritoneovenous shunt. Inception to maturity |
| Q69440438 | The phrenic pacemaker. Substitution of paralyzed functions in tetraplegia |
| Q44930697 | The physiologic characteristics of transformed skeletal muscle for cardiac assist |
| Q38641556 | The place of the peritoneovenous shunt in the treatment of ascites. |
| Q44469103 | The possibility of improving biocompatibility by removing anaphylatoxins from the circuit of blood-perfused artificial organs |
| Q68245723 | The potential of a microencapsulated urease-zeolite oral sorbent for the removal of urea in uremia |
| Q68644856 | The quest for the permanent LVAD. We must continue, we must push forward |
| Q42112460 | The real impact of mechanical bridge strategy in patients with severe acute infarction |
| Q34482339 | The relevance of urea kinetic modeling to CAPD. |
| Q45276713 | The reliability of a compressed mixture of insulin and palmitic acid to sustain a reduction in hyperglycemia in rodents. |
| Q68786090 | The role of artificial organs in restoration of laryngeal function |
| Q69361368 | The role of beta receptors in the peripheral vasculature of calves with a total artificial heart |
| Q67977094 | The role of biomaterials science in the next generation of artificial organ technology |
| Q69361375 | The role of the protein C-thrombomodulin system in physiologic anticoagulation during cardiopulmonary bypass |
| Q69403780 | The spindle pump. Development of a nonpulsatile blood pump for assisted circulation |
| Q46448843 | The three-dimensional relationships between mitral and tricuspid valvular annuli for total artificial heart implantation |
| Q54403470 | The total artificial heart. A better model to study the hemodynamic effect of protamine. |
| Q69780022 | The use and complications of three peritoneal dialysis catheter designs. A retrospective analysis |
| Q39557508 | The use of DC electric fields to promote regeneration in the mammalian nervous system |
| Q68202054 | The use of a paracorporeal ventricular assist device as a bridge to cardiac transplantation |
| Q69403677 | The use of image processing in the investigation of artificial heart valve flow |
| Q67780320 | The use of the Gianturco intravascular stent in stenotic hemodialysis fistulas |
| Q67780529 | The valvo-pump. An axial, nonpulsatile blood pump |
| Q69403863 | The wish for renal transplantation |
| Q69658330 | Therapeutic effect of a left ventricular assist device on acute myocardial infarction evaluated by magnetic resonance imaging |
| Q51615240 | Therapeutic effects of simvastatin on hyperlipidemia in CAPD patients. |
| Q69403830 | Therapeutic plasmapheresis for liver failure after hepatectomy |
| Q36480539 | Thermal effects of far ultraviolet excimer laser radiation on biologic tissue |
| Q69403614 | Thirty-five years of progress. ASAIO 1989 |
| Q67819738 | Three-dimensional interface geometry of the human heart with the artificial heart |
| Q67780200 | Thrombin generation in cardiac device recipients |
| Q33456526 | Thrombocytopenia in neonates after extracorporeal membrane oxygenation |
| Q46023702 | Thromboembolic complications with the Pierce-Donachy ventricular assist device. |
| Q68622771 | Thromboembolytic complications during circulatory assistance with a centrifugal pump in patients with valvular prostheses |
| Q48941550 | Thrombus in a natural left ventricle during left ventricular assist: another thromboembolic risk factor. |
| Q67780452 | Tidal peritoneal dialysis. Urea and total nitrogen losses |
| Q68622811 | Time and pressure dependence of sieving coefficients during membrane plasma fractionation |
| Q69658372 | Tissue developed around bioresorbable implants. Load-bearing versus histology |
| Q69559499 | Total pericardial replacement. Design and preliminary evaluation in greyhounds |
| Q61662607 | Total solute extraction versus clearance in the evaluation of standard and short hemodialysis |
| Q69440380 | Toward a completely implantable TAH. A left-right simultaneously ejecting motor-driven TAH system |
| Q69440488 | Toward an implantable impeller total heart |
| Q69714847 | Trace elements in dialysis patients |
| Q69658363 | Trace metals and anemia in chronic hemodialysis patients |
| Q52097705 | Transcatheter placement of an intraluminal prosthesis for the thoracic aorta. A new approach to aortic dissections |
| Q41283400 | Transcellular disequilibrium and intradialytic catabolism reduce the reliability of urea kinetic formulas. |
| Q69403650 | Transcellular urea gradients cause minimal depletion of extracellular volume during hemodialysis |
| Q69403909 | Transesophageal color Doppler echocardiography during mechanical assist circulation |
| Q67780229 | Transesophageal echocardiography for the evaluation of mitral valve prostheses in the weanling sheep |
| Q45364579 | Transmural blood flow of multi-layered latissimus dorsi skeletal muscle ventricles during circulatory assistance |
| Q69658425 | Treatment of chronic inflammatory demyelinating polyradiculoneuropathy by plasma filtration |
| Q69440479 | Treatment of iron overload in continuous ambulatory peritoneal dialysis patients |
| Q43720984 | Tumor necrosis factor clearances during veno-venous hemodiafiltration in the critically ill. |
| Q46038348 | Turning point in the management of pregnancies complicated by diabetes. Normoglycemia with self blood glucose monitoring of diet and insulin dosing. |
| Q67780404 | Two-dimensional mechanical and ultrastructural correlates of bovine pericardium for prosthetic valves |
| Q69440508 | Ultra-short dialysis and internal physiologic resistance |
| Q69403800 | Ultrafiltration of dialysis fluid for hemodialysis |
| Q54293752 | Univentricular support results in reduction of pulmonary resistance and improved right ventricular function |
| Q41155773 | Urea monitoring during dialysis: the wave of the future. A tale of two cities |
| Q52426633 | Urea, creatinine, uric acid, and phosphate spaces and their relationship to total body water during chronic hemodialysis. |
| Q67780450 | Uremic myopathy and calcitriol therapy in CAPD patients |
| Q48938050 | Urinary incontinence. An introduction |
| Q69440408 | Use of a capillary filtrate collector for monitoring glucose in diabetics |
| Q69403898 | Use of a total right heart bypass model for analyses of abnormal hemodynamics in total artificial heart animals, and the function and regulatory mechanisms of a natural heart |
| Q67780467 | Use of an intravascular oxygenator/carbon dioxide removal device in an ovine smoke inhalation injury model |
| Q69658375 | Use of polyethylene-lined silicone rubber cannulae in long-term insulin infusion in the dog |
| Q68786085 | Use of the Hickman catheter as permanent vascular access for hemodialysis |
| Q45941424 | Use of umbilical vessels for neonatal ECMO cannulation: possibilities and precautions. |
| Q43684937 | Using magnostrictive metal as a pump for biomedical application |
| Q68622698 | Various methods for calculation of Kt/V: a clinical comparison |
| Q54293745 | Vascular access for extracorporeal circulation. Resistance in double lumen cannulas |
| Q44442149 | Vasoactive hormones during hemodialysis with intermittent ultrafiltration |
| Q41931085 | Venovenous extracorporeal life support in neonates using a double lumen catheter |
| Q51766429 | Venovenous perfusion of adults and children with severe acute respiratory distress syndrome. The Pennsylvania State University experience from 1982-1987. |
| Q69440462 | Vented ECMO for biventricular failure |
| Q69658452 | Vented cardiac assistance: ECMO versus left heart bypass for acute left ventricular failure |
| Q70311570 | Ventilatory impact of partial extracorporeal CO2 removal (PECOR) in ARF patients |
| Q44290439 | Ventricular assist device volume compensation using a two phase fluid. |
| Q67780352 | Ventricular assist with heparin surface coated devices |
| Q69440368 | Ventricular interaction during right ventricular assist |
| Q68622891 | Venturi grafts for hemodialysis access |
| Q33285051 | Venturi pressure cannot cause cavitation in mechanical heart valve prostheses |
| Q69626304 | Vibrofluidized bed coating of hemoperfusion adsorbents |
| Q69440448 | Visual evidence of concentration polarization in cross-flow membrane plasmapheresis |
| Q36438452 | Vortex shedding in bileaflet heart valve prostheses |
| Q44132558 | Waterborne Pseudomonas septicemia |
| Q70134853 | When and how should dialysis be withdrawn? |
| Q68531911 | Withdrawal of therapy |
| Q67780439 | Zinc-mediated lymphocyte energy charge modification in dialysis patients |
Search more.